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λexc: excitation wavelength 
λem: emission wavelength 
ADIBO: azadibenzocyclooctyne  
ADPA: anthracene dipropionic acid 
AIBN: azobisisobutyronitrile 
APF: 2-[6-(4'-Amino)phenoxy-3H-xanthen-3-on-9-yl] benzoic acid 
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CPY: commercial peroxy yellow 
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DCM: dichloromethane 
DCFH: 2,7-dichlorodihydrofluorescein  




DMA: dimethyl anthracene 
DMF: dimethylformamide 
DMSO: dimethyl sulfoxide 
DNA: deoxyribonucleic acid 
DPA: diphenyl anthracene 
EPR: enhanced permeability and retention 
ESI: electron spray ionization 
ESR: electron spin resonance 
EtOH: ethanol 







HPF: 2-[6-(4'-hydroxy)phenoxy-3H-xanthen-3-on-9-yl] benzoic acid 
HPLC: high performance liquid chromatography 
MsCl: methanesulfonyl chloride 
MS: mass spectra 
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NBS: N-bromosuccinimide 
NHS: N-hydroxysuccinimide 
NMR: nuclear magnetic resonance 
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PBS: phosphate buffer solution 
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PLGA: polylactic-co-glycolic acid 
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PrxIII: peroxiredins 
PVA: polyvinyl alcohol 
POY: peroxy yellow 
RhB: rhodamine B 
RNS: reactive nitrogen species 
ROS: reactive oxygen species 
SOD: superoxide dismutase 
SOSG: superoxide sensor green 





TFA: trifluoroacetic acid 
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Reactive oxygen species (ROS) play important roles for the regulation of normal 
functions such as proliferation, differentiation, migration and cell death. At low doses 
they participate in the redox balance, but an excess of these species leads to damage 
to proteins, lipids or DNA. ROS are involved in the onset and progression of several 
degenerative diseases (e.g., cancer, neurological disorder, etc). Cancer cells are 
highly susceptible to ROS-mediated damage and several chemotherapy agents 
achieve cytotoxicity by inducing oxidative stress.  
Sensing the variations of different intracellular ROS is crucial for real time assessments 
of anticancer treatment efficiency. Yet, no sensor currently allows simultaneous and 
independent monitoring of different ROS live cells. Indeed, existing sensors monitor 
either the total levels of ROS or the levels of single species (i.e., sensors such as 
diphenylanthracene, peroxy yellow, anthrafluorescein, etc.).  
The need to optimise and personalise treatment regimens and for unravelling the 
mechanisms underpinning ROS-induced cell death requires the introduction of a new 
set of tools able to provide a real-time report of intracellular ROS levels in response to 
a given intervention.  
In this project we developed new fluorescent nanosensors able to respond to different 
ROS. This was achieved through the synthesis of three conjugatable molecular probes 
able to respond to individual ROS, namely; an anthrafluorescein-based probe for 
superoxide anion, a dimethylanthracene-based probe for singlet oxygen and a 
fluorescein-based probe for hydrogen peroxide. The new probes were grafted onto 




conjugated or encapsulated sensors. We characterised the fluorescent response of 
the probes, conjugates and nanospecies in the presence of the target ROS analytes. 
Lastly, we demonstrated the ability of the nanosensors to enter cells and their potential 





























Chapter 1. Introduction 
1.1. Reactive oxygen species (ROS) 
1.1.1. What are ROS? 
ROS are derivatives of molecular oxygen characterised by a high reactivity1–3. Different 
species of ROS exist: some have an unpaired electron and display the typical reactivity 
of radicals (e.g., superoxide radical (O2•-), hydroperoxyl radical (HO2•), hydroxyl radical 
(HO•), peroxyl radical (ROO•) and alkoxyl radical (RO•)), wheras other species react 
as electrophiles (hydrogen peroxide (H2O2) and hypochlorous acid (HOCl)) and/or as 
oxidative agents (singlet oxygen (1O2)) (Fig. 1.1).  
 





1.1.2. Cell production of ROS 
Between the 80% and 90% of the ROS produced by cells are formed in mitochondria 
during the electron transport chain 5–10 (Fig. 1.2 & 1.3). Superoxide anions are formed 
from molecular oxygen in the third compartment of the mitochondria. To prevent 
superoxide-mediated toxicity (see below), these anions are transformed into hydrogen 
peroxide by an antioxidant enzyme called superoxide dismutase (SOD). Due to its 
higher stability, hydrogen peroxide is a relatively long-lived ROS compared to 
superoxide anion and it can diffuse out of the mitochondria. In the cytosol, catalase 
(CAT) and other antioxidants such as glutathione peroxidase (GPx) or peroxiredins 
(PrxIII) can transform hydrogen peroxide into water. Ferrous ions can reduce hydrogen 
peroxide to form hydroxyl radicals. Hydroxyl radicals can in turn react with superoxide 
anions to form oxygen and water as a further detoxification step. NADPH oxidase 
(NOX)11, present in the cell membrane, can also form superoxide anions outside the 
cell, which can be transformed into hydrogen peroxide and enter the cell. Superoxide 
anions and hydrogen peroxide can also be transformed into reactive nitrogen species 
(RNS) (nitric oxide (•NO), peroxynitrite (ONOO-)) or chlorinated ROS (hypochlorous 
acid (HOCl)). A further ROS source is the degradation of lipids and alcohol in the 
peroxisome. ROS can also be formed as a result of external stimuli, for example, under 











Figure 1.3: Transport of ROS in cells12 
1.1.3. Reactivity of ROS 
Electrons are more stable when they are paired, this gives radicals less stability 
compared to non-radical species and can explain their reactivity. Indeed, the two main 
features of ROS (i.e., short lifetime and limited diffusion range) are more prominent for 
ROS radicals16. The less reactive a molecule is, the longer its lifetime and the farther 




in a wider spatial range from the generation site (Tab. 1.1). The most reactive ROS is 
the hydroxyl radical followed by the superoxide radical and singlet oxygen. Compared 
to those three, hydrogen peroxide is less reactive and can diffuse over a longer 
distance. 




Hydroxyl radical 1 ns 1 nm 
Superoxide anion 1 µs 30 nm 
Singlet oxygen 1 µs 30 nm 
Hydrogen peroxide 1 ms 1 µm 
 
ROS display different reactivity profiles, which in turn define the biomolecules they are 
able to modify7,16–18: superoxide radical reacts with double bond-containing 
compounds (e.g., unsaturated fatty acids), while hydroxyl radicals will react with double 
bond-containing compounds as lipids19 and DNA20, but also with hetero-atoms (e.g., 
sulfur or nitrogen) on proteins21 leading to crosslinking, oxidation or hydrolysis. 
Hydrogen peroxide oxidizes proteins, whereas reactions of singlet oxygen with 
proteins, polyunsaturated acids or DNA often occur via Diels-Alder reaction. Some 













Reaction of ROS with biomolecules can lead to modification/damage of proteins, lipids 
and nucleic acids. In order to avoid these damages, the intracellular levels of ROS are 
carefully controlled by antioxidant species, such as SOD (Eq. 1.1)25, CAT (Eq. 1.2)26–
29 GSH (Eq. 1.3) or NADPH (Eq. 1.4)30. 





Equation 1.2: CAT effect on hydrogen peroxide26 
     
Equation 1.3: Glutathione effect on hydrogen peroxide30 
 
Equation 1.4: NADPH effect on oxygen30 
     
1.1.4. ROS participation in cell homeostasis and oxidative stress 
At low or moderate levels, ROS participate in the physiological homeostasis of the 
cell9,32–34. ROS are involved in regulating development, differentiation, stress signalling 
and cell death7,32,33,35–38 (Fig. 1.4). For example, ROS are linked with the proliferation 
and survival of cells by mitogen-activated protein kinase cascades or phosphoinositide 
3-kinase pathway, with iron homeostasis or with homeostasis and antioxidant gene 
regulation by Nrf2 and Ref1-mediated redox cellular signaling39. One example of the 
implication of ROS in cell survival processes is the activation of the tumour suppressor 
protein p5334,40,41. p53 is extremely important in the control of cellular stress responses, 
inducing either cell cycle arrest in order to promote DNA repair and survival, or cell 
death by apoptosis42, depending on the context. 
An imbalance between ROS and antioxidants can have various consequences. If an 
excess of antioxidant exists, the cell proliferation pathway is affected and this can lead 
to malformation or dysfunction such as cardiomyopathies43 or neurodegenerative 
disorders44. An excess of ROS causes a phenomenon called oxidative stress, which 




neurodegenerative diseases17, diabetes50,51, aging52–54, hypertension55,56) (Fig. 1.4 
and 1.5). 
 





Figure 1.5: Impact on cancer of different level of ROS and ROS-related gene 
regulation57 
Oxidative stress occurs when the balance between antioxidants species such as 
glutathione (GSH/GSSG)58 (Eq. 1.3) or (NADPH/NADP+) ratios (Eq. 1.4) and ROS shift 
in favour of ROS. This imbalance results in the damages to biomolecules discussed in 
Section 1.1.325.  
Cancer cells display a high susceptibility to oxidative stress, an effect known under the 
name of "the Warburg effect"8. This behaviour is exploited by several therapeutic 




cancer cells. Externally induced production of ROS is the warhead of a therapeutic 
approach called photodynamic therapy (PDT) (Fig. 1.6)8,59–62. This therapy relies on 
the generation of ROS through the irradiation of a photosensitizing chemical compound 
with non-toxic visible light to inactivate target cell (e.g., cancer cells or microorganisms) 
and eradicate infections or ablate cancer and precancerous tissue63. PDT leads to cell 
death either via apoptosis34,37,40,64, which is called programmed cell death or 
necrosis62, which is due to outside trauma or depletion of vital substances.  
 
Figure 1.6: PDT process65 
Apoptosis66 is morphologically characterized by chromatin condensation, cleavage of 
chromosomal DNA into internucleosomal fragments, cell shrinkage, membrane 
blebbing and formation of apoptotic bodies without plasma membrane breakdown. 
Typically, apoptotic cells release “find me” and “eat me” signals required for the 
clearance of the remaining debries by phagocytic cells. At the biochemical level, 
apoptosis entails the activation of caspases, a highly conserved family of cysteine-
dependent aspartate-specific proteases. Necrosis66 is morphologically characterized 
by vacuolization of the cytoplasm, swelling and breakdown of the plasma membrane 
resulting in an inflammatory reaction due to release of cellular contents and pro-
inflammatory molecules. Necrosis is thought to be the result of pathological insults or 




with cell survival. The biochemistry of necrosis is characterized mostly in negative 
terms by the absence of caspase activation, cytochrome c release and DNA 
oligonucleosomal fragmentation. 
1.1.5. Approaches for the detection and quantification of ROS 
The importance of ROS in the redox homeostasis of the cell and their role in triggering 
toxicity and potentially cell death (see previous sections) compelled scientists to 
develop viable approaches for ROS detection and quantification in biological 
environment. Because of their short life and their short range of action, the detection 
and quantification or ROS had to rely on the development of bespoke analytical 
tools67,68. 
Electron spin resonance (ESR) is a technique that permits the direct identification of 
oxygen free radicals. Because of their short lifetime, specific reagents are used to 
stabilize these radicals, either by addition of a covalent bond (the molecule is called a 
spin trap)69 or by oxidation of the molecule (the molecule is called a spin sensor)68. 
Spin traps are more often used than spin sensors. The most popular spin trap is 5,5-
dimethyl-1-pyrroline-N-oxide70,71, which is useful in solution but has limited applicability 
in most biological systems due to competing reactivity with SOD and ascorbate that 
partially inhibits formation of product. Furthermore, its range of efficient concentration 
is limited, as it must be used with ROS concentrations between 20 and 100 mM72,73, 
which do not make it a sensitive technique. Another spin trap is 5-diethoxyphosphoryl-
5-methyl-1-pyrroline N-oxide74, which can be modified to have a triphenylphosphonium 
group to promote its selective uptake by mitochondria75. The main limitations of this 




detected), its toxicity to cells and non-specificity to superoxide 76–79. Moreover, this this 
spin trap does not allow quantification of ROS and is also expensive68. 
Chemiluminescent sensors are high potential tools for ROS detection, in particular for 
superoxide anion, for their sensitivity and ease of use16. The principle is that the sensor 
reacts with the ROS and the reaction leads to the release of a photon that is detected 
by a photometer without excitation by a light source68,71. Lucigenin is one the sensors 
used for superoxide anion measurement in macrophages and neutrophils69,80. One 
drawback of lucigenin is the susceptibility of the chemiluminescent species to reduction 
in the presence of flavoprotein reductase81, which in turn increases the level of 
superoxide anions. In addition, the chemiluminescent species can react with other 
molecules such as hydrogen peroxide68, reducing the specificity of the detection. 
Luminol is also used but is less selective because it reacts with hydrogen peroxide, 
hydroxy radicals and peroxynitrite and increases the level of those ROS (Eq. 1.5)82–84. 
This represents a serious drawback for the accurate quantification of ROS. 
Equation 1.5: Lucigenin intermediate reduction 
 
Superoxide is also detected by cytochrome c (Cc) reduction coupled with 
spectrophotometry 67,68. Cc can be reduced by superoxide anions from the ferri- to the 
ferro- form, causing an alteration of the absorbance at 550 nm, which can be detected 




superoxide anion with enzymes or reductants as xanthine oxidase, ascorbate or 
glutathione, which in turns hampers its quantification with this method68. 
Last but not least, fluorescent sensors can be used to detect different types of ROS. 
Two types of fluorescent sensors exist: protein-based sensors and small organic 
molecules. Protein-based sensors are designed through the combination of fluorescent 
proteins and prokaryotic redox sensitive proteins67,68. These sensors can provide 
real-time and dynamic detection of redox state change. Sensors of different colours 
are available, for example green (redox-sensitive green fluorescent protein85 type 1 or 
2), yellow (redox-sensitive yellow fluorescent protein86 combined with glutaredoxin-187 
or charged with 3 residues88) or red (redox-sensitive red fluorescent protein89). These 
species are biocompatible but slow-reacting and not very sensitive, which does not 
allow accurate quantification of ROS68. Organic sensors are species whose fluorescent 
behaviour is modified following reaction with ROS. A large panel of fluorescent sensors 
exists with different properties, such as wavelengths of emission and excitation, 
selectivity, and ability to enter cells or selectively accumulate in intracellular organelles 




Table 1.3: Summarize of the different methods for ROS analysis 
 
1.1.6. Fluorescent sensors for ROS 
The possibility of correlating the fluorescence intensity with the concentration of the 
ROS makes fluorescent sensors particularly attractive for the quantification of reactive 
oxygen species concentration in cells67,68,90. The vast array of sensors developed to 






1.1.6.1. Superoxide anion sensors 
As previously described, the superoxide anion is the first ROS generated by the 
mitochondrial electron transport chain. Even if this ROS is unstable because of its 
radical nature, some sensors can successfully detect and quantify it (Tab. 1.4)3. Most 
selective sensors developed can only be used in a limited range of pH. 
1.1.6.2. Hydrogen peroxide sensors 
Hydrogen peroxide is the most stable ROS, therefore easier to detect and quantify. 
However, the sensors designed to detect hydrogen peroxide often react with other 
more reactive ROS, leading to lack of selectivity of the sensors themselves. (Tab. 1.5)3. 
Most of the selective sensors developed have a lack of selectivity. 
1.1.6.3. Singlet oxygen sensors 
Singlet oxygen is not directly created by cells. The formation of this ROS is induced by 
an endogenous or exogenous photosensitiser following irradiation during PDT59–61,91–
93. Given its importance for ROS-based therapeutic approaches such as PDT, some 
sensors have been developed to detect and quantify singlet oxygen (Tab. 1.6). 
Sensors for singlet oxygen tend to be quite selective and they respond to the analyte 
by either increasing (turn-on sensors) or decreasing (turn-off sensors) their 
fluorescence emission intensity; the main difference is the analysis, whether 
measuring an increasing or decrease in the fluorescence. 
1.1.6.4. Hydroxyl radical sensors 
The hydroxyl radical is the most reactive ROS, yet a number of sensors for its detection 
have been developed (Tab. 1.7). Most of these are selective to the hydroxyl radical, 


















oxidative burst in 
cells 
•Cytochrome c can oxidize it 
•High (1a) concentrations increase 
fluorescence because of connection 
with DNA 
•(1a) increases superoxide 
dismutation to peroxide 
•(1a) can be oxidized by peroxide via 
non-specific peroxidase catalysis and 
make some interference  










•Good indicator in 
phospholipid 
liposomes 
•Non-selective (react with singlet 
oxygen) 









• Emission is optimal at pH between 


















• Emission is optimal at pH between 





















•Diacetate (1b) form 
can be applied in cell 
studies (DCFDA) 
•Useful marker of 
oxidative stress 
•Non-selective 
•Cellular peroxidase important for 
oxidation or catalase and SOD 
•Cytochrome c, peroxidases, hematin 
increase formation of DCF 
•Photo reduction of DCF by visible 












•Widely used as a 
hydrogen peroxide  
monitoring sensor, 
either isolated in 
mitochondria 
 or in stimulated 
neutrophils and 
eosinophils 
•Decrease of fluorescence 
•Low selectivity 
•Low extinction coefficient 
•Interference from autofluorescence 
•Need amplification 
•Low stability in biological media (pH 
and temperature) 
•Interference from reductive 
compound (NADPH, NADH, ascorbic 













•Stable from pH 7.5 to 
8.5 
• Low selectivity 















•Useful to detect the 
production of 
hydrogen 





















depending on the R 
variety (as 
triphenylphosphonium 
group in MitoPY1) 
•Selective 





• Evaluation of 
scavenging activity. 
•Cationic and lipophilic 
sensors 
•Non-selective 









Table 1.6: Fluorescent sensors for singlet oxygen 
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•Initial reactive is fluorescent too and 
with the same wavelength 
•Extinction of fluorescence in acid 
conditions (Cl or F are added to 












•Less hydrophobicity than DPAX 
•Initial molecule has a low fluorescence 
Singlet oxygen sensor 
green (SOSG)60,63,90,107,130–













Table 1.7: Fluorescent sensors for hydroxyl radical 









•Initial molecule has a low fluorescence 
•Need DMSO to generate CH3•  





•Need DMSO to make HCOH and not 
possible for cell 
Sodium terephtalate139 
  






•Fluorescence depends on the pH 









•COOH increase the 





•Fluorescence depends on the pH 
•Depends on where hydroxylation is 



















•COOH increase the 











(HPF or APF)147 
  
500/520 •HPF is selective 
•Fluorescence is suppressed in 
presence of DMSO 
•APF reactive with HOCl 








Fluorescence with HO• 











Nanoparticles (NPs)149 are a family of particles characterised by their size: regardless 
of shape, a particle is defined as a “nanoparticle” if one of its dimensions is from 1 to 
100 nm150,151. 
One of the many classifications of NP is based on their composition:  
• Carbon-based NPs such as fullerenes and carbon nanotubes. Fullerenes152,153 
are football-shaped cages made of sp2 hybridized carbon. Fullerenes C60 and 
C70 have diameters of 7.114 and 7.648 nm respectively. Carbon nanotubes154 
have a tubular structure with a diameter between 1 and 2 nm. 
• Metal NPs are mostly made of copper, silver or gold. Gold NPs155 have been 
obtained in a variety of shapes, such as nanospheres, nanorods, nanoshells 
and other geometric shapes (tetrahedra, octahedra, cubes, icosahedra). 
Depending on their shapes, gold NPs have different sizes. For example, 
nanorods have a cross-section of around 50 nm in nanocages, but a nanoshell 
will have a diameter of around 140 nm. Depending on their shape and size, gold 
silver and copper NPs will have different optical properties. 
• Ceramic NPs are inorganic non-metallic species. They can have different 
forms, ranging from amorphous to dense solids with different ranges of 
porousity156. One of the most widely inorganic NPs is made of silicon157–160. 
• Semiconductor NPs are made of metallic and non-metallic materials such as 




• Polymeric NPs (or PNPs) are organic NPs. They often appear as nanospheres 
or nanocapsules. They can be functionalised on the surface to conjugate a 
variety of species. Examples of polymers used to obtain nanoparticles are 
polylactic-co-glycolic acid (PLGA), polyethylene glycol (PEG), poly(methyl 
methacrylate), poly(N,N-dimethylacrylamide) 151,162–165, and polysaccharides166. 
• Lipid-based NPs are NPs with lipid moieties. They form spheres with a 
diameter between 10 and 1000 nm167.  
The approaches to make NPs can be divided in two broad classes 168,169: 
• bottom-up synthesis, producing nanoparticles from small molecules or atoms 
• top-down synthesis, producing nanoparticles from larger species. 
As shown in Figure 6, because of their size, morphology and properties (optical170, 
thermal171,172, magnetic173,174 or mechanical175) NPs are suitable for a wide array of 
applications. Their use is still a controversial matter because of their potential 
toxicity154,176,177: for example, their absorption by inhalation, their distribution in the 
body and long exposure effects are not fully characterised or known and their long-
term effect in the environment is also still the object of debate149. Numerous 
applications of NPs in the therapeutic and diagnostic fields have been explored178–180. 
NPs are regarded as advantageous drug delivery agents because they can increase 
drug efficiency and reduce side effects on patients181. NPs are also used in 
manufacturing processes in several sectors (medical, commercial, ecological, 
microelectronics, aerospace or pharmaceutic sector182–185), in environmental 
applications (evaluation of their risk 186 or absorption of contaminants187,188), as well as 





1.2.2. NPs as a support for sensors 
A prominent biomedical application of nanoparticle relies on their potential for the 
development of nanosensors. The advantages of using a NP as the support for a 
sensor are listed below192–195:  
• The use of molecular sensors exhibiting unfavourable properties for biological 
measurements (e.g., poor aqueous solubility, uneven distribution due to 
sequestration, chemical interference, or toxicity) can be enabled by 
encapsulating them in a nanoparticle.  
• The NP protects the sensing component from interference caused by species 
present in biological environments (e.g., undesirable enzymatic reactions and 
nonspecific uptake by proteins).  
• Nano-sized structures have a high surface-area-to-volume ratio, which 
determines a higher probability for analyte detection.  
• Because a single nanosensor can carry a large number of molecular sensors, 
NPs can increase the local concentration of the sensor, thereby enhancing the 
intensity of the response signal.  
• Because of their size, which is much smaller than the size of biological cells, 
NPs cause minimal physical perturbations to cells or tissues while 
measurements are undertaken. Also, this favours the detection of unstable 
analytes with limited diffusion distances as ROS. 
• ROS sensitive molecular sensors are chemically unstable and encapsulating 
them into NPs can improve their stability.  
• Nanosensors can be provided with different reactive functional groups 




• Nanosensors can be targeted to specific cells or tissues of interests by 
conjugating target-specific ligand moieties onto the NP surface. 
These advantages, combined with the potential offered by fluorescent sensing to 
quantify ROS level, fostered the development of fluorescent nanosensors for one or 
more ROS. Thus, a wide array of nanosensors were developed, exploiting different 
methods to generate a fluorescent signal following the reaction with the target 
analyte(s). Thus, ROS nanosensors based were described194, based on a polymeric 
or micelle matrix (for fluorescent dyes196–200 or chemiluminescent dyes201–204) or 
metallic matrix (for fluorescence quenching205–207, NP surface energy transfer208 or 
surface enhanced Raman scattering/spectroscopy209). 
The first report of this application concerned the synthesis of a Photonic Explorer for 
Bioanalysis with Biologically Localised Embedding (PEBBLE)200. This nanosensor 
consists of DCFDA encapsulated in hydrophobic ORMOSIL (ORganic MOdified 
SILica) NPs194–196,210,211. DCFDA, a derivative of DCFH, is a sensor for hydrogen 
peroxide. As discussed above, DCFDA suffers lack of selectivity, and responds to other 
ROS and to species such as peroxidase. The presence of the hydrophobic ORMOSIL 
nanoparticles greatly enhances the selectivity of the sensor by creating different 
barriers for non-target analytes (i.e., a size barrier, which prevent large species like 
peroxidase and esterase from reaching the sensor; a time barrier, which prevents 
access of highly reactive hydroxyl radicals; and hydrophobic energy barrier for most 
other ROS). Thanks to the presence of the NP, the fluorescent sensor DCFDA gains 





Figure 1.7: Schematic representation of induced H2O2 selectivity by encapsulating 
DCFDA into relatively hydrophobic ORMOSIL NPS196 
SOSG133 and anthracene dipropionic acid (ADPA)134, used to detect singlet oxygen, 
were covalently linked to polyacrylamide NPs without linkers (A), with linkers (B), or 
with trimethylphosphonium groups (C) which were introduced to enhance the 
penetration in mitochondria96,212.(Fig. 1.8). This study demonstrated that the 
nanosensor was more effective in detecting singlet oxygen compared to the stand-
alone sensor134. It was also shown that the nanosensors (nanoSOSG) could detect 





Figure 1.8: Conjugation of ADPA or SOSG to functionalized polyacrylamide NPs 
directly (A), via a spacer (B) and with positively-charged trimethylphosphonium 
groups (C)133 
Nanosensors for superoxide were also reported, describing the encapsulation of RhB, 
DBZTC or Tpy-Cy in mesoporous silica nanoparticles (MSN)213 (Fig. 1.9). In these 
ratiometric sensors, rhodamine B was used to localise NPs because its emission is not 
affected by the fluctuation of pH or levels of superoxide anion, and its signal can be 
used as reference. DBZTC is used to sense superoxide levels and Tpy-Cy for pH 
sensing. These nanosensors proved useful to study the influence of superoxide and 




described, triphenylphosphonium (TPP) groups were included to improve the ability of 
the sensor to enter mitochondria. 
 
Figure 1.9: Illustration of the nanosensor formation and the structures of RhB, 
DBZTC, and Tpy-Cy213 
PEBBLE nanosensors with a matrix of amine-functionalized polyacrylamide and CCA 
covalently attached on the surface were synthesised198. Because of the short range 
and lifetime of this ROS, the fluorescent molecular sensor was positioned on the 
surface of the nanoparticle, and Texas Red-Dextran was encapsulated in the matrix to 




reactive ROS (Fig. 1.10). This study showed that the large surface-to-volume ratio of 
the nanoparticle allowed a greater sensing area for this ROS. 
 
Figure 1.10: Hydroxyl radical PEBBLE sensor198 
1.2.3. Summary 
the involvement of ROS in biological processes fuelled the development of analytical 
tools to identify and quantify these short-lived species. Amongst the various 
approaches, the use of fluorescent labels holds a great potential because of their 
specificity and their ability to quantify ROS concentration. The potential of fluorescent 
sensors was further expanded by the development of nanosensors. The use of 
nanoparticles proved useful to detect and quantify ROS made impressive progresses 
since its inception, providing further confirmation that the use of a nanoparticle support 
greatly broadens the applicability of fluorescence ROS sensing.  
This work aims at contributing to its field by exploring the possibility of sensing 





Aim of the work 
As discussed in the introduction, the use of a NP as a support for ROS fluorescent can 
have real advantages to address and overcome of the lack of selectivity, potential 
toxicity and instability of some of the fluorescent ROS molecular sensors194. The 
involvement of ROS in homeostatic processes in the cell needs to be fully 
characterised, especially the role of different ROS and how their levels fluctuate in the 
cells in different physio-pathologic conditions. To the best of our knowledge, a sensing 
device that allows this kind of analysis has not been described so far, and this project 
will address this knowledge gap. 
The aim of this project is to design and synthesise novel polymeric nanosensors to 
monitor, in real time and concurrently, the levels of different ROS, in order to further 
the understanding of the impact of ROS on the homeostatic or pathological state of 
cells. 
The works will be articulated along the following objectives: 
1) synthesis of the sensors 
2) synthesis of the nanosensors 
3) investigation of the sensing response in the presence of the target analytes 
To achieve the project aim, the choice of the fluorescent sensors is crucial. When using 
multiple sensors, wavelengths of excitations and emissions need to be carefully 
chosen, so that they do not overlap, leading to signal interference. In order to covalently 
link the sensors to the polymeric nanoparticle matrix, they also need to bear a suitable 




The structure of the target nanosensor is illustrated in Figure 1.11. The support of the 
nanosensor is a PLGA-based NPs with three orthogonal functional groups that are 
able to react with three conjugation partners on the fluorescent sensors (A). The choice 
of the structures of the fluorophores comprises:  
• Novel modified boronated fluorescein (yellow fluorescent) for hydrogen 
peroxide detection with a carboxylic group that can react on an amine on the 
NPs (B). 
• Novel modified hydroethidine (red fluorescent) for super oxide anion detection 
with an azide group that can react on a terminal alkyne on the NPs (C), 
• Novel modified DPAX (green fluorescent) for singlet oxygen detection with an 





Figure 1.11: Target nanosensors design. Modified HE (A), DMAX (B), fluorescein 





Chapter 2. Synthesis and fluorescence behaviour of new 
functionalized molecular sensors 
As described in the previous chapter, the selection of the three sensors was made on 
the basis of their reported selectivity toward the target analyte, their wavelengths of 
excitation and emission, and on the potential to introduce suitable functional groups. 
We chose known ROS probes selective towards different ROS that emit with light at 
different wavelength (i.e., different colour) and we devised a strategy to insert a 
functional group to allow conjugation. For those reasons, we selected structures of HE 
(1a) for superoxide, DMAX (14a) for singlet oxygen and peroxy yellow (POY) (23a) for 
hydrogen peroxide.  
2.1. Superoxide sensor 
2.1.1. Hydroethidine 
2.1.1.1. Synthetic approach 
Zielonka and collaborators described and approach to introduce a substituent bearing 
a phosphonium group onto hydroethidine to obtain a species able to target 
mitochondria96,100. As discussed in the previous section, we aimed at providing 
hydroethidine with an azide group to exploit CuAAC chemistry for conjugation to 
alkyne-derivatised nanoparticle (Fig 2.1). We reasoned that choosing either a 
carboxylic group or an aldehyde group as the conjugation handle would potentially lead 






Figure 2.1: Design of desired molecule from (1a) 
To obtain the target superoxide sensor we followed the synthetic strategy reported by 
Chu et al. (Scheme 2.1). According to this approach, the aromatic amino groups on 
hydroethidine are protected with a Boc group to avoid reaction with the alkyl halide in 
the following steps. Alkylation of the endocyclic nitrogen is then carried out with a 
suitable alkyl halide and lastly the protecting group is removed. The reduction of 
hydroethidium (27) into hydroethidine (28) is reported to occur in the presence of 
NaBH3CN96,97,214–219. Considering the nature of our target side chain on hydroethidium 
(27), the use of a mild reducing agent such as NaBH3CN seemed suitable, as it would 






Scheme 2.1: Synthetic approach for (28). (i) Boc2O, THF, water, NaHCO3; (ii) I-R; (iii) 
HCl 4M in 1,4 dioxane; (iv) NaBH3CN, 0°C. 
2.1.1.2. Boc protection of (24a or 24b) 
On analysing commercial hydroethidine (24a) by 1H-NMR, we observed that this 
species is very quickly oxidised into (24b) in contact with air (Fig. 2.2). Although 
unexpected, this behaviour did not hamper our synthetic approach, because (24b) can 
be a substrate for the synthetic transformations we intended to carry out. Chu et al., 
proposed a synthetic approach to protect (24b) primary amine group with a Boc 
group220 (Sch. 2.1). The reaction was carried out by treating hydroethidine with 7 
equivalents of Boc2O in water and THF in an ice bath. The mixture was stirred at 0 °C 
for 30 minutes and at room temperature overnight. The desired compound was 
obtained as a yellow solid with a yield of 69%. Purification by column chromatography 
was not possible because the compound proved unstable on silica, so it was used for 




of degradation, but we speculate that the acidity of silica may have led to the loss of 
Boc groups: following column chromatography we observed on the mass spectra the 
presence of hydroethidine (HE), and of the monoprotected derivative (1 BOC HE) and 
with two Boc groups (2 BOC HE) (Fig. 2.3).  
 






Figure 2.3: Mass spectra of (25) after purification by column chromatography (ES+). 
 
2.1.1.3. Alkylation of side chain with functionalised moiety 
2.1.1.3.1. Synthesis of chain (31)  
In order to conjugate our sensor on NPs, a suitably functionalised linker must be 
introduced on the hydroethidine moiety. We decided to add a spacer between the 
hydroethidine and the azide to avoid interference of the latter with the sensing structure 
and to minimise the risk of steric hindrance during the conjugation to the nanoparticle. 
Our choice fell on 1-azido-2-(2-(2-ethoxy)ethoxy)ethane (Scheme 2.2), as it can be 
readily obtained from commercially available 2-(2-(2-chloroethoxy)ethoxy)ethanol (29). 
In addition, this linker displays a PEG-like structure that potentially improves the water 
solubility of the sensor, thereby facilitating the conjugation to the nanoparticle, which 
occurs in water221. The first step involves the replacement of the chloride on (29) with 




which entails the nucleophilic displacement of a chloride with an iodide, is carried out 
in acetone. The insolubility of sodium chloride in acetone subtracts the chloride ions 
from the solution and drives the reaction to completion, affording the desired iodide in 
high yield. The second step of the synthesis involves the displacement of the iodide 
with azide, performed in boiling AcCN in the presence of NaN3 as described by Kele 
et al.223 (Sch. 2.2). 
 
Scheme 2.2: Synthesis of chain (31). (i) NaI, acetone, reflux; (ii) NaN3, AcCN, reflux 
2.1.1.3.2. Attachment of the chain (31) on (25) 
In order to attach the chain on the Boc-protected (25), we first explored the possibility 
of using the mesylate of alcohol (31) as a derivative that is easier to handle compared 
to the triflate used by Lee et al. 224. The mesylate was obtained by treatment of (31) 
with MsCl in the presence of TEA, in DCM at 0°C (Sch. 2.3). Reaction of the mesylate 
(32) with (25) was attempted in refluxing acetonitrile: we verified that under these 
conditions no formation of the desired species took place. We speculated that the lack 
of reactivity we observed could be either due to the moderate nucleophilicity of the 
phenanthroline nitrogen of (25), making the mesylate insufficiently electrophilic for this 





Scheme 2.3: Alkylation of (25) by (31). (i) MsCl, TEA, DCM, 0°C; (ii) (25), AcCN, 
reflux. 
We attempted to circumvent this problem by using an iodide as the alkylating reagent, 
as outlined below. 
2.1.1.3.3. Synthesis of chain (34) 
In order to obtain the target iodide, (29) was transformed into 1-azido-(2-(2-
chloroethoxy)ethoxy)ethane (33). To this end, the hydroxyl group was mesylated as 
indicated above. Then, the mesylate was treated with TBAI and NaN3 and refluxed in 
toluene until TLC indicated complete conversion (2 days)225,226 (Sch. 2.4). 
Replacement of the chloride by an iodide, was carried out in the same conditions 





Scheme 2.4: Synthesis of chain (34). (i) MsCl, TEA, toluene, 0°C; (ii) TBAI, NaN3, 
toluene, reflux; (iii) NaI, acetone, reflux. 
2.1.1.3.1. Attachment of the chain (34) on (25) 
To attach the chain on the Boc-protected hydroethidine (25), similar conditions to the 
ones described above were adopted (Sch. 2.5). Unfortunately, after 2 weeks of reflux 
conditions, the desired molecule was not obtained as verified by mass spectra (Fig. 
2.4). The peak at 486.1351 shows that the starting material was still present in the 
reaction mixture. 
 





Figure 2.4: Mass spectra of (26) 
Our hypothesis to explain the failure of this reaction is the choice of the chain. N-
alkylated heterocycles such as phenanthroline can lose the alkyl group under various 
conditions, including heating227. In our case, the loss of the alkoxyethylene chain can 
be tentatively rationalised with the formation of an alkyloxyranium intermediate, which 
would facilitate the elimination (sch. 2.6). 
 





2.1.1.3.2. Alkylation and azidation using 1,3-diidodopropane 
In the first instance, we attempted the incorporation of an azide group using a shorter 
chain without oxygen. As shown by Huber et al., the alkyl chain is introduced on 
hydroethidine first and the azide moiety is added later (Sch. 2.7).1,3-diidodopropane 
(35) was refluxed in the presence of hydroethidine (25) in THF for 5 days216. 
Unfortunately, no reaction was observed after 5 days but it eventually progressed to 
completion in 2 months (monitored by MS). The procedure reported in the literature 
does not mention this extremely long reaction time, therefore we concluded that the 
use of the Alloc group has a considerable effect on the reactivity of the pyridine 
nitrogen. This might be due to its stability in acidic and basic conditions228. After the 
completion of the reaction, a yellow solid (36) was collected with 61% of yield. 
For the introduction of the azide group, the alkylated protected hydroethidine was 
refluxed with sodium azide in a mixture of acetone and distilled water in proportion 3 





Scheme 2.7: Synthesis of (26c). (i) THF, reflux, (ii) NaN3, acetone/water (3:1), reflux. 
2.1.1.4. Reduction and deprotection  
According to the procedure reported by Chu et al., the reduction step was carried out 
at 0°C in THF using NaBH3CN as the reducing agent. Subsequent treatment with 4 M 







Scheme 2.8: Reduction and deprotection of (26c). (i) NaBH3CN, THF, 0°C; (ii) 4M 
HCl in 1,4-dioxane. 
After reduction and deprotection of (26c)220, the mass spectra shows that the reaction 
struggled to reach completion. On one hand, Boc deprotection was not completed as 
indicated by the peaks at [M+100] and [M+200] for one or two Boc protecting groups, 
respectively, on the mass spectrum (Fig. 2.5). On the other hand, the oxidized 
molecule was still present in the solution. Two additional treatments with NaBH3CN 
were made following the previous procedure to reduce the oxidised species. 
Unfortunately, the reaction was not complete and after few days, the reduced molecule 
(mass 369.4046) reverted to its oxidised form (mass 371.3177) (Fig. 2.5). The apparent 
lack of stability of alkylated hydroethidine led us to conclude that its use as a ROS 
sensor would be severely affected. In fact, the reduced form of (28a) is non-fluorescent 




analyte, the detection and eventual quantification of superoxide anion would be 
biased94,218. In addition, the lengthy reaction times necessary for its synthesis 
contributes to making the use of alkylated hydroethidine unviable.  
 









As discussed in the introduction alternative probes exist to detect superoxide anion. 
One of them is phosphinated dianthrafluorescein (4a). Although the literature reports 
conflicting information on the absorption/emission wavelengths (λexc/λem = 602/662 
nm108 or λexc/λem = 490/530 nm109) we selected phosphinated dianthrafluorescein 
because it is reported to emit in the red window of the spectrum and synthetic 
approaches to introduce functional groups amenable to conjugation are relatively 
straightforward (Fig 2.6). 
 
Figure 2.6: Design of desired molecule from (4a) 
2.1.2.1. Synthetic approach 
The dianthrafluorescein sensors described in the literature do not bear a functional 
group that allows their conjugation; therefore, we needed a synthetic strategy to obtain 
a phosphinated dianthrafluorescein derivative suitable for this project. Our approach, 
depicted in (Sch. 2.9), started with a Friedel-Craft reaction followed by ring closure to 
give the dianthrafluorescein scaffold. The insertion of the azide group on the chain 






Scheme 2.9: Synthetic approach for (43). (i) CH3SO3H, 100°C (ii) CuCl2, Na2S2O8, 
90°C; (iii) DIC, NHS, THF at rt; (iv) 2-(2-azidoethoxy)ethan-1-amine, TEA, DCM/DMF 
at rt; (v) P(O)Ph2Cl, TEA, THF at rt. 
Benzene-1,2,4-tricarboxylic acid and naphthalene-1,6-diol reacted in methanesulfonic 
acid in a tandem Friedel-Craft acylation and ring closure110 to afford the target product 
(39a and 39b) (Sch. 2.10) as a mixture of isomers that are not readily separable by 





Scheme 2.10: Friedel and Craft mechanism for the formation of dianthrafluorescein 












Figure 2.7: Separation of the two isomers (20a) and (20b) by LC 
The closure of the 5-membered lactone was achieved by oxidation with copper chloride 
and sodium persulfate (Sch. 2.11)229 to form a red solid (40) in 69% yield. 
 
Scheme 2.12: Synthesis of the alkyl chain (46). (i) Boc2O, THF, water, NaHCO3; (ii) 
MsCl, TEA, DCM, 0°C; (iii) (5), AcCN, reflux. 
As planned for hydroethidium, we aimed to insert an azide group on the fluorophore to 
conjugate it to the polymer via a CuAAC “click” reaction. To make the alkyl chain (46), 
2-(2-aminoethoxy)ethan-1-ol (44) was Boc-protected as previously described for 
hydroethidine (25)220. The following step is a mesylation as described for species (31) 
and lastly the displacement of the mesylate by azide was carried out with sodium azide 




The carboxylic group in dianthrafluorescein (40) was activated with NHS (Sch. 
2.9)231,232 in the presence of DIC to give a red solid (41) in 98% yield. 
To obtain the target amide, (46) was treated with TFA in DCM (2:5) to remove the Boc 
protecting group and the resulting amine (46a) was coupled with (41)233 in presence of 
TEA234,235 to give a red solid (42) with 62% of yield (Sch. 2.13). 
 
Scheme 2.13: Alkylation of (41) by (46). (i) TFA/DCM, (ii) TEA, DCM/DMF. 
The phosphination of (42) was carried out with (Ph2P(O)Cl)108 (Sch. 2.9) in THF. We 
verified that the addition of Ph2P(O)Cl must be carried out at 0°C and the reaction 
performed at room temperature in order to avoid the degradation of the chain and the 
recovery of dianthrafluorescein, which was indicated by the presence of a peak at 
477.0754 on the MS (Fig. 2.8). These conditions led to the desired product (43) in 23% 






Figure 2.8: Mass spectra of (43) after room temperature reaction (ES+) 
2.1.2.2. Spectroscopic characterisation  
(43) has an absorption maximum at 490 nm and an emission maximum at 540 nm (Fig. 
2.9), as expected from the literature (490 and 530 nm)109. This value is rather close to 
the emission of the POY sensor for hydrogen peroxide (see section 1.2) and could lead 
to signal interference. 

























As a preliminary exploration of the efficiency of this sensor (43), its reactivity with 
superoxide anions was tested in aqueous solution. Superoxide anions were generated 
with xanthine (Xa) and xanthine oxidase (XO)13,96,100,107,109. The sensor was dissolved 
in DMSO and the resulting solution was diluted in PBS. PBS has been chosen because 
its pH (7.4) is similar to the pH of the cytoplasm in the cells (7.2). To this solution Xa 
and catalase solutions were added. Then different volumes of XO solution were added. 
Fluorescence spectra of the samples were recorded at 560 nm (Fig. 2.10a) and the 
intensity of the maximum of emission was plotted versus the added volume of XO (Fig. 
2.10b). 
 
Figure 2.10: Example of fluorescence emission of (43) depending on XO volume. 
Fluorescence spectra of the samples (a), plot of normalised fluorescence versus 
added volume of XO (b). 
As shown in Fig. 2.10 the fluorescence intensity increases between 0 and 15 µL and 
decreases from 15 µL. We speculated that this decrease could be due to the change 
of pH of the medium, which has is reported to have a considerable effect on the 
intensity of fluorescence emission of fluorescein-based species. As our experiments 
were performed in buffered solutions, we were inclined to rule out a pH effect in the 




dependence reported for dianthrafluorescein. As shown in Figure 2.11, 
dianthrafluorescein emits efficiently between 7.4 and 8.0108.  
A further possible explanation for the unexpected variation of emission intensity lies in 
the changes of emissive behaviour due to the interactions of the fluorophores with 
proteins and other biomacromolecules196, which has been observed for SOSG133: the 
XO enzyme in our solution can bind with our sensor and alter its fluorescence. In this 
case the use of NPs can be advantageous as it will help to protect our sensor from 




Figure 2.11: Effect of the pH on (43)108 
Our work aimed at the synthesis of a superoxide sensor bearing an azide group for 
conjugation on polymeric nanoparticle led us to explore the functionalisation of a 




lack of stability. As an alternative sensing moiety, we selected dianthrafluorescein. The 
synthesis of the target species was successful, and the sensor showed a promising 
superoxide-dependent emissive behaviour, although we observed some unexpected 
variation of fluorescence emission. This behaviour was tentatively attributed to the 
interaction of the sensing moiety with the protein in the system (XO), an issue that will 
be potentially circumvented by the conjugation of the sensor with the NPs. 
2.2. Hydrogen peroxide 
2.2.1. Modified peroxy yellow sensor: boronated group directly attached to the 
fluorescein 
As discussed in the introduction, POY is a useful sensor used for hydrogen peroxide 
detection. Peroxy yellow is based on fluorescein with a boronated group that reacts 
selectively with this ROS. A peroxy yellow sensor substituent bearing a phosphonium 
moiety that enhances the ability of the sensor to enter mitochondria has been reported 
and is referred to as mitoPY (Fig. 2.12)101,236–238. This species inspired us to synthesise 
a peroxy yellow with a substituent bearing a conjugatable group for conjugation to the 
polymeric matrix of the nanoparticle. We chose to introduce a carboxylic group on the 
peroxy yellow scaffold because of its versatility towards conjugation via amidation and 





Figure 2.12: Design of desired molecule from (10a) 
 
The reaction scheme was adapted from an approach described in the literature101. The 
main challenge was to adapt it to insert another side chain with a carboxylic group 
(Sch. 2.12).  
The synthetic approach proposed by Dickinson et al. starts with a Friedel-Craft reaction 
to make 2-(2,4-dihydroxybenzoyl)benzoic acid (49).Species (49) then reacts with 3-
(piperazin-1-yl)phenol to form the fluorescein moiety (51). Then, the nitrogen on the 
piperazine is protected with an Fmoc group and the free phenolic OH is transformed 
in the corresponding triflate. Finally, boronate is added to replace the triflate, Fmoc 
group is removed and the desired carboxylic group is introduced by acylation of the 






Scheme 2.14: Reaction scheme for (54), (i) AlCl3, nitrobenzene; (ii) TFA; (iii) Fmoc-
Cl, NaHCO3, AcCN; (iv) N-phenyl bis(trifluoromethanesulfonamide) NaHCO3, DMF; 
(v) Boron pinacol ester, Pd(dppf)Cl2∙ CH2Cl2, sodium acetate, toluene; (vi) Piperidine, 




Isobenzofuran-1,3-dione (48) and resorcinol (47) react under Friedel-Craft conditions 
in the presence of AlCl3239 (Sch. 2.15). After recrystallisation, benzophenone (49) was 
obtained as a pale green powder with 60% of yield.  
 
Scheme 2.15: Friedel and Craft to obtain (49) 
Cyclization to the fluorescein derivative was performed using TFA (Sch 2.16). In the 
following steps of the synthesis, the -NH on piperazine ring is protected with a Fmoc 
group (Fig. 30)101. Dickinson et al. rationalise their choice of the Fmoc as a protecting 
group because its removal with piperidine does not damage the structure of the probe. 
Thus, 2,4-dihydroxybenzoyl)benzoic acid (49) and 1-(3-hydroxyphenyl)-piperazine 
(50) were treated in TFA under anhydrous conditions under a flow of argon. The 
desired product was precipitated by addition of diethyl ether and careful fast filtration 
to maintain the product as a solid and prevent the formation of a sticky residue. The 
crude was dissolved in methanol and evaporated to dryness to remove any residual 





Scheme 2.16: Mechanism of fluorescein “body” 
The following step consisted in the triflation of the hydroxyl group (Sch. 2.14)101,240. 
This reaction was necessary for the subsequent palladium-catalysed Suzuki coupling 
between the boron pinacol ester and aryl triflate, which gives a one-step entry to 
organoboronates from organic electrophiles. To this end, (51) was allowed to react with 
N-phenyl bis(trifluoromethanesulfonamide) in the presence of sodium carbonate at 




The mechanism of the palladium-catalysed coupling reaction between the diboron 
pinacol ester and aryl triflate101,238 starts with the oxidative addition of the aryl triflate 
(52) to the palladium catalyst to give aryl palladium(II) species R-Pd(II)-Tf (Sch. 2.17). 
Then, a ligand exchange takes place between Tf of R-Pd(II)-Tf and the boronate to 
produce the R-PdII-B(OR)2 intermediate during the transmetallation step and the 
subsequent reductive elimination affords the arylboronate along with the regeneration 
of the catalyst (Sch. 2.17). The reaction was performed in toluene in a microwave 
sealed tube for 4 hours101 using [1,1′-
bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane 
(Pd(dppf)Cl2∙CH2Cl2) as the catalyst. Flash chromatography afforded the desired 





Scheme 2.17: Mechanism of coupling cycling using Pd(II) 
Species (53) needed to be modified to introduce a carboxylic group to allow 
conjugation to the NP. To make this possible, the -NH on piperazine was 
deprotected101 and then acylated with succinic anhydride241 (Sch. 2.14). The reactivity 
of the anhydride allows the acylation to occur with no need for activation of the 
carboxylate with NHS and DIC. The boronated derivative (53) was treated with a 
solution of 15% of piperidine in acetonitrile at room temperature for 40 minutes. The 




and the solution was cooled to 0°C. Succinic anhydride was added slowly. The reaction 
mixture was warmed to room temperature and stirred overnight. The solvent was 
removed under reduced pressure to give a pink solid. The desired product could not 
be purified from piperidine-Fmoc adduct (Fig. 2.13), as it decomposed on silica during 
column chromatography. The instability of the product on silica is also suggested by 
the 2D TLC shown in Fig. 2.14.  
 
Figure 2.13: Mass spectra of crude (54) (ES+) 
 






The unexpected instability of (54) on silica was inconvenient as it prevented us from 
purifying the final fluorescent sensor101. We set out to devise an alternative approach 
to add the boronated group and obtain the desired product as a pure species. 
2.2.2. Modified peroxy yellow with a linker between boronated group and 
fluorescein 
2.2.2.1.  Synthetic approach 
 
Scheme 2.18: Reaction scheme for (58), (i) AlCl3, nitrobenzene; (ii) TFA; (iii) succinic 
acid, DIPEA, DMF; (iv) (57), K2CO3, DMF. 
Following the challenges posed by the purification of (55) from the Fmoc and DIPEA 
adduct, we devised a variation on the previous synthetic approach that avoids Fmoc 
protection and deprotection steps (Sch. 2.18). The first step proceeds through a 
Friedel-Craft acylation as previously described239, then the nitrogen on the piperazine 




this approach the boronate group is introduced by nucleophilic substitution, attached 
to a benzoyl moiety, as outlined in Scheme 2.18. The boronate group guarantees that 
the molecule displays the desired reactivity towards hydrogen peroxide to reveal 
fluorescein (Sch.2.19)242–244. In addition, this synthetic approach has the advantage of 
being shorter with fewer steps and avoid the triflation and palladium catalysed coupling 
steps. 
 




The Friedel-Craft adduct (49) reacts with phenol (50) in TFA as described previously101 
to give the fluorescein scaffold. Acylation with succinic anhydride in the presence of 
DIPEA led to the formation of (56) as a red solid in a yield of 54%. This synthetic 
approach was higher yielding than the one leading to (51), which afforded the target 
compound in 42% yield. Introduction of the boronate was achieved through a 
nucleophilic substitution of the phenolic oxygen in (56) on boronated benzyl bromide 
(57). The reaction was carried out in DMF in the presence of potassium carbonate at 
room temperature to give a red sticky solid (58) in 38% yield.  
Although compound (58) showed sign of degradation on silica (e.g., multiple spots on 
TLC), its isolation from the reaction mixture is easier and the whole process is higher 
yielding (overall 12% yield vs. 6% to obtain (54)). The molecule was stored in freezer 
under nitrogen to minimise exposure to air and potential degradation at room 
temperature.  
2.2.2.2. Spectroscopic characterisation 
The absorption and emission behaviour of the sensor were investigated. The excitation 
and emission maxima are at 515 nm and 540 nm respectively, which are in line with 

























Figure 2.15: Excitation and emission of sensor (58) 
A preliminary test of the responsiveness of this sensor (58) to hydrogen peroxide was 
carried out in the presence of different amounts of hydrogen peroxide in buffered 
aqueous solution (PBS, pH = 7.4)242. The fluorescence spectra at different 































Figure 2.16: Example of the fluorescence emission with increasing hydrogen 
peroxide concentration  
Unexpectedly, we observed a very slight decrease of the intensity of emission, which 
is in contrast with the behaviour reported in the literature101.  
It has been reported that pH has a considerable influence on fluorescein emissive 
behaviour, resulting in changes of both absorption/emission wavelengths and intensity 
of emission (Fig. 2.17)245; this is ascribed to the presence of the carboxylic group on 
the molecule. Because we carried out the experiments in buffered solution, we were 





Figure 2.17: pH dependence of fluorescein (a) and HPF (b) absorption245. 
Crucially, performing repeated measurements on the same sample we observed a 
similar reduction of intensity of emission (Fig. 2.18)101. This led us to hypothesise that 
the decrease in emission intensity may arise from the tendency of fluorescein to bleach 






























Figure 2.18: Example of the fluorescence emission with 980 nmol of hydrogen 
peroxide depending on time of exposure 
Mass spectra (Fig. 2.19) taken before and after the reaction with a large excess 
hydrogen peroxide and shows that (58) has disappeared ([mass + K+]: 753.3179) and 





Figure 2.19: Mass spectra of (58) before and after reaction with hydrogen peroxide 
(ES+) 
A further hypothesis to explain the degradation could involve the formation of a quinone 
structure from fluorescein, a behaviour that was reported in the literature (Fig. 2.20)247, 
although we did not find evidence of the putative compound (58a) on the MS spectra. 
We were unable to isolate the individual components present in the solutions of probe 
and hydrogen peroxide, which prevented analysis by NMR to further elucidate the 
mechanism of degradation underpinning the decrease in fluorescence emission. 




response to hydrogen peroxide was evaluated for this sensor conjugated to a polymer, 
as discussed later in this work (chapter 3). 
 
 
Figure 2.20: Oxidation of fluorescein (a) and hypothesis for (58) (b) 
With compound (58) we achieved our goal to synthesise a boronated fluorescein probe 
endowed with a carboxylic group to allow conjugation to amino-functionalised 
polymeric nanoparticle matrices. Probe (58) was designed following the major 
shortcoming of the initial target probe (54), namely its instability on silica, which 
prevented its purification. Probe (58) offers the advantage of a shorter synthesis (three 
vs. five steps) and although it still displays an unsatisfactory stability on silica, it can be 
isolated and purified by crystallisation. In the presence of hydrogen peroxide, (58) 
displays an unexpected loss of intensity of fluorescence emission, a behaviour that 




fluorescein moiety. The conjugation of the sensor with the NPs could be advantageous 
to limit or slow down the degradation of the sensing moiety. 
2.3. Singlet oxygen 
As discussed in chapter 1 (section 1.1.6), DMAX was our initial target scaffold for 
singlet oxygen detection. The synthetic approach to obtain analogues of DMAX 
(DPAX248 or Aarhus Sensor Green130) are reported in the literature, but the main 
challenge for us was to incorporate a functional group suitable for conjugation that 
display no cross-reactivity with ligation approaches involving the groups present on 
(48) and (53) (Fig 2.21). Our goal was to insert an aldehyde moiety to allow conjugation 
to NPs functionalised with an oxyamino group. 
 
Figure 2.21: Design of desired molecule from (14a) 
2.3.1. Modified DMAX 
2.3.1.1. Synthetic approach 
The synthetic strategy to obtain the target species is based on reported approaches to 
obtain DMAX-based sensors (Sch. 2.20). Although the synthetic route to DMAX-based 




considerably from the published syntheses because of the need to introduce a 
conjugatable function. In particular, our challenge was to introduce two different groups 
on positions 9 and 10 of the anthracene moiety in DMAX.  
 
Scheme 2.20: Proposed synthetic approach for modified DMAX (69). (i) AlCl3, DCM; 
(ii) KMnO4; (iii) H2SO4; (iv) acetic anhydride; (v) SMe3I, NaH, DMSO, THF; (vi) LiCl; 
(vii) Zn/HCl, (viii) PCC; (ix) diethyl (2-(1,3-dioxan-2-yl)ethyl)phosphonate; (x) H2, 




Firstly, we envisaged to perform a Friedel-Craft acylation of benzoyl chloride (59) on 
trimethylbenzene (60) to obtain (61)249. The product would then be oxidized to the 
corresponding tricarboxylic derivatives249 and treated with strong acid to give quinone 
(63)249. The two free carboxylic group would be transformed in the corresponding 
anhydride and treatment of the quinone anhydride with trimethylsulfonium iodide would 
afford the bis-epoxide in position 9 and 10250,251. Lithium chloride would then be used 
to open epoxide to form an anthracene bearing an aldehyde and an alcohol by 
Meinwald rearrangement250. This step would give the desired differentiation of 
reactivity of positions 9 and 10 on the anthracene. The aldehyde group would be then 
reduced to a methyl group via a Clemmensen reduction252 and the primary alcohol 
would be oxidised to the corresponding aldehyde by treatment with pyridinium 
chlorochromate253. In order to increase the distance between the anthracene moiety 
and the conjugation site, which could sterically hinder the ligation to the nanoparticle, 
a Wittig-Horner would be carried out to install the desired protected aldehyde group 
farther away from the fluorophore254. Finally, the scaffold of DMAX would be obtained 
through a Friedel and Craft according to procedures described in the literature130. 
Following this strategy, benzoyl chloride and 1,2,4-trimethylbenzene were treated with 
AlCl3 under Friedel and Craft conditions (Sch. 2.20)248,249,255 to give the desired product 
(61) in 98% yield. 
Different approaches to oxidise (61) are available (Sch. 2.21). The first we explored256 
relied on the use of KMnO4 as the oxidant, which unfortunately gave a very low yield. 
A two-step method was then attempted, which relied on the reaction of (61) with HNO3 
in water at reflux for 5 days, followed by the treatment of the resulting yellow solid with 




achieve the target triacid by carrying out the oxidation with KMnO4 in pyridine at 50°C 
for 5 days257.  
 
Scheme 2.21: Oxidation of (61) 
Ring closure of (62) occurs via treatment with a strong acid: heating the starting 
material at reflux in concentrated H2SO4 for 3 hours afforded a brown solid from which 
the desired compound was isolated in 2% yield. We attributed this low yield to the fact 
that the previous steps were carried out on the crude products248,249,255,258. The highly 
hydrophilic products of the previous steps were challenging to purify due to the 
presence of two/three carboxylic groups, a considerable difference from the 
unsubstituted ring described in the literature248,249. A possible approach to overcome 
this challenge could involve the esterification of the carboxylic groups to make the 
products more amenable to purification by column chromatography on silica, followed 
by a base-catalysed hydrolysis on the purified species. Although this strategy would 
allow purification, we decided not to pursue it as it would add two synthetic steps and 
depending on the yields and could easily result in no overall advantage. We reasoned 
that despite the low yield, the approach we followed provided the desired compound 




synthesis, the carboxylic groups of (63) were protected as the phthalic anhydride (Sch. 
2.20)259 to avoid the reaction with sodium hydride and the methylating agent Me3Si, as 
this would result in the formation of an ester. To perform this step (63) was treated with 
anhydrous acetic acid for different periods of time (1.5h, 4h and 1 day) in carefully dried 
glassware. After 24 hours, 62% of the desired species was obtained. We found that 
the hydrolysis to the parent dicarboxylic acid was very easy, so we stored the 
compound in vacuum at 35°C to ensure removal of water without causing degradation 
on the compound. 
As mentioned above, epoxidation and treatment of the resulting species with LiCl is a 
viable strategy to differentiate the reactivity of the two carbonyl functions on the 
anthracene moiety. The epoxidation has been reported in the literature on non-
substituted and dibromo-substituted anthracene quinones250,251,260–264, and it occurs in 
the presence of SMe3I following deprotonation with sodium hydride to give the 
sulfonium ylide (Sch. 2.22). 
 
Scheme 2.22: Corey-Chaykovsky epoxidation mechanism251 
We attempted the reaction on our substrate according to the procedure reported by 




of NaH and SiMe3I, but unfortunately the desired product was not obtained. This was 
deduced from the fact that the expected mass for the target species at 306 was not 
present on the mass spectra of the crude (Fig. 2.22): the presence of a peak at m/z = 
281 indicated the reduction of the anthraquinone to anthracenediol. We speculate that 
it occurs by action of sodium hydride as a base, nucleophile and a reducing agent (Sch. 
2.23)265. 
 
Figure 2.22: Mass spectra after epoxidation (ES+) 
 
Scheme 2.23: Hypothetic reactional mechanism to form anthracenediol265 
Repeated attempts to perform this reaction using different ratios and molar excess of 
the reagents led to the same results. We concluded that the presence of the two 
carboxylic functions alters the reactivity of the quinone groups compared to the one 
reported for the dibromoanthraquinone248.  
An alternative synthetic strategy to obtain the target structure would involve the use of 




as indicated in Scheme 2.24, and subsequently introducing the carboxylic groups as 
cyanide group. We did not undertake the approach due to the Health and Safety 
implications of performing the reaction248. 
 
Scheme 2.24: Other synthetic approach to obtain DMAX248 
We then explored the possibility of introducing the target aldehyde group on the 
anthraquinone through a Wittig reaction266. We treated (63) with potassium tert-




equivalent of the latter reagent because our aim was to functionalise only one carbonyl 
group. Unfortunately, we observed no reaction and we were only able to recover 
unchanged (63) from the reaction mixture.  
2.3.2.  Modified DMA 
In view of the challenges encountered in the synthesis of a functionalised DMAX 
derivative, we changed our target singlet oxygen sensor to a DMA derivative (Fig. 
2.23). Keeping in mind that the target sensor should emit at a different wavelength as 
the other species so far obtained, (X) and (Y), and that it needs to bear a functional 
group suitable for conjugation, our choice for the fluorophore fell on 9,10-
dimethylanthracene for both its reactivity and its blue fluorescence. A major difference 
between this sensor and the fluorescein-based sensors is that the intensity of its 
fluorescence emission decreases upon reaction with singlet oxygen3. As the reactive 
functionality for conjugation with the polymer we chose to insert a carboxylic group.  
 







2.3.2.1. Synthetic approach 
Although it would be possible to attempt the epoxidation on anthraquinone263, we 
chose to follow a simpler synthetic approach because of time constraints. We 
envisaged introducing a carboxylic group as for the hydrogen peroxide sensor on only 
one or both methyl groups on the DMA. To achieve that, the methyl group(s) will be 
brominated267 and then reacted with malonic acid268 to give the modified DMA (Sch. 
2.25). 
 
Scheme 2.25: Synthetic approach for (72a) and (72b). (i) NBS, AIBN, AcCN; (ii) Na, 
EtOH, diethyl malonate; (iii) NaOH, MeOH, CHCl3, (iv) heat. 
Firstly, we attempted the bromination on only one of the methyl groups, using the 
conditions reported by Andrus et al.267. To this end, DMA was treated with one 
equivalent of NBS in presence of a catalytic amount of AIBN in AcCN at reflux. This 
approach led to the formation of mono- and di-substituted derivatives as well as 
unreacted DMA, in a mixture that proved laborious to resolve. To circumvent this 




2.25) to favour the formation of the di-substituted derivative (71b), which was obtained 
with a yield of 98%. 
Insertion of the carboxylic acid was carried out by displacement of the bromides with 
diethyl malonate. The reaction exploits the relative acidity of the alpha methylene to 
generate the corresponding carbanion. Following Martinez et al. procedure (Sch. 
2.26)268,269, diethyl malonate was treated with sodium ethoxide, generated from sodium 
in absolute ethanol. Following addition of the brominated DMA (71b) the mixture was 
refluxed for 4h. Saponification was carried out by NaOH in MeOH. After the reaction, 
the solution was acidified to pH = 1 by using concentrated HCl to precipitate the 
product. After filtration, spontaneous decarboxylation was achieved by maintaining 
compound (76) under vacuum at 120°C for 5 days to give a light green solid with 18% 





Scheme 2.26: Malonic synthesis. (i) Na, EtOH; (ii) (72b), benzene; (iii) NaOH, MeOH, 
CHCl3, (iv) HCl; (v) 120°C, under vacuum, 5h. 
2.3.2.2. Spectroscopic characterisation  
The absorption and emission profile of compound (72b) were studied. Excitation and 
emission maxima were found at 325 nm and 425 nm (Fig. 2.24), which are in line with 
the values reported in the literature (375 and 436 nm)3. This molecule absorbs in UV 






















Figure 2.24: Excitation and emission of sensor (72b) 
Preliminary studies of the responsiveness of this sensor to singlet oxygen were carried 
out in the presence of a photosensitiser with irradiation. Rose Bengal is often 
considered the photosensitiser of choice to perform these studies because of its high 
photodynamic efficiency270. In our case, though, Rose Bengal is not an ideal 
photosensitiser because it displays an absorbance band at 470 nm: as shown in figure 
2.24, and DMA emits at this wavelength. A very efficient class of photosensitisers that 
absorb at favourable wavelengths are porphyrins. For this reason, we chose 
5,10,15,20-tetrakis-(N-methylpyridinium-4-yl)porphyrin tetrachloride zinc(II) complex 
(Fig. 2.25), which has an intense absorption at ca. 400 nm and is efficient in promoting 





Figure 2.25: Zn-porphyrin complex 
Thus, a solution containing both compound (72b) and the photosensitiser was 
irradiated with blue light (400 nm) and the emission spectrum of (72b) was recorded at 






Figure 2.26: Example of fluorescence emission of sensor (73b) with singlet oxygen. 
Spectra (A) and plot of normalised fluorescence (B). 
As expected, when exposed to singlet oxygen, the fluorescence intensity of (72b) 
decreases (Fig. 2.26a). Figure 2.26b, shows that the decrease is more marked at the 
beginning than at the end that is going to the limit of detection. This behaviour may be 




2.4. Chapter conclusion 
We successfully obtained two new species (43) and (58) and one known molecule 
(72b) with the structural features of ROS sensors and with suitable functional group to 
perform the conjugation to the polymers. 
Attempts to obtain functionalised HE (28) failed, therefore an alternative 
dianthrafluorescein-based sensor for superoxide was designed and synthesised. 
Phosphonated dianthrafluorescein (43) was provided with an azide group to allow NPs 
conjugation based on the CuAAC reaction.  
After a failed attempt to obtain a hydrogen peroxide sensor bearing a boronate group 
directly attached to the fluorescein skeleton (54), a suitable sensor bearing the 
boronate group attached to a benzoyl linker was obtained. This modified fluorescein 
sensor (58) was functionalised with a carboxylic acid.  
The synthesis of a singlet oxygen sensor based on DMAX (69) was attempted but not 
achieved because of the difficulty to achieve reaction on a single carbonyl of the 
anthraquinone moiety (epoxidation or Wittig reaction). An alternative singlet oxygen 
responsive species based on dimethylanthracene derivative bearing a carboxylic 
group was obtained (72b).  
The new sensors showed promising fluorescent behaviour. In fact, despite a 
dependency of the signal on pH, we observed for (43) an increase of the intensity of 
emission when the concentration of superoxide increased. But no major pH variations 
are expected in the cell, with or without ROS, so the impact of the pH dependency of 
the emission on the sensing process may be limited. The responsiveness of the sensor 




intensity, but conjugation to a polymer will be undertaken to study the behaviour of the 
conjugate in the presence of hydrogen peroxide. The expected fluorescent behaviour 
of the sensor (72b) was observed with the presence of singlet oxygen. 
Fig 2.27 reports the excitation and emission profiles of (43), (58) and (72b). The 
emissions of (43) and (58) partially overlap and the emission spectra of (72b) is close 
to the excitation wavelength of (43), so (43) may absorb light emitted from (72b). This 
characteristic will be analysed in the next chapter. 
































Chapter 3. Synthesis and fluorescence behaviour of nanosensors 
Following the synthesis of the molecular sensors, we turned our attention to the 
synthesis of polymer conjugates of the sensors to obtain the target NPs (nanosensors). 
The initial idea was to make PLGA NPs containing three different functionalities for 
orthogonal conjugation of the various sensors (43, 58 and 72b) (Fig 3.1). As illustrated 
in Chapter 2 (section 2.1 and 3.1), both the modified DMA and the modified POY 
display carboxylic acid group. Although it would be possible to modify either of these 
by introducing a heterobifunctional linker273, we chose to carry out the conjugation of 
each single sensor to the polymer and then use a mixture of the different conjugates 
to obtain the target nanoparticles. For the polymeric matrix of the nanoparticles we 
chose PLGA, a biocompatible and biodegradable polymer that allows straightforward 
functionalisation. This Chapter also discusses the analysis of the nanosensors 
responsiveness (fluorescence and selectivity) to the presence of the different ROS 
analytes.  
 







3.1. Conjugation between PLGA and molecular sensors 
PLGA is a polymer commonly used in medicine and drug delivery as reviewed in the 
first chapter (Fig. 3.2)151,159,164,165,274–277. It is approved by the United States of 
America Food and Drug Administration (FDA) because of its biodegradability and 
biocompatibility. PLGA is a co-polymer composed of lactic acid and glycolic acid. 
Depending on the ratio of lactic-to-glycolic acid, the properties of PLGA can be tuned 
to meet the requirements of a variety of applications, giving this polymer a great 
versatility162. The end-groups of the PLGA chain are a carboxylic group and a primary 
alcohol, both of which can be exploited for conjugation. Strategies for the 
derivatisation of the single COOH on the chain are widely reported in the literature274.  
 
Figure 3.2: PLGA structure 
3.1.1. (58) and (72b) on PLGA 
Both (58) and (72b) have a carboxylic group as does PLGA, therefore a linker needs 
to be used to allow conjugation of these species. We chose 1,2-diaminoethane as a 
homo-bifunctional linker, as it can form amide bonds with both carboxylic groups. 
Because evidence of limited stability emerged during synthesis and purification of 
sensors, we performed the conjugation of the linker on the polymer first. The reaction 
was carried out in THF in the presence of N-hydroxysuccinimide and N,N'-




1,2-diaminoethane to minimise the possibility of polymer cross-linking. The reaction 
was carried out overnight and the modified polymer was recovered by precipitation with 
diethyl ether and centrifugation. Sensors were added on the modified polymer using 
the same approach (Sch. 3.1). All steps were verified by Fourier-transform infrared 
spectroscopy (FTIR) by monitoring the appearance of the amide peaks following 
attachment of the linker and sensor278 (amide C=O stretch between 1690 – 1630 cm-1 
and amide N-H stretch between 3500 – 3180 cm-1) (Fig. 3.3 & 3.4). Because of the 
variability of PLGA chain size and the important molecular weight compared to our 
molecule, experimental data (like NMR or MS) can’t prove the conjugation of sensors 
to the polymer, but the polymer had the colour of the sensor and no washing removed 












Figure 3.3: Evolution of FTIR of formation of (58)-PLGA 
  





3.1.2.  (43) on PLGA 
To allow conjugation with azide-bearing (43) the polymer needed to be functionalised 
with a triple bond. Azide can react with terminal alkynes in CuAAC with the presence 
of the pair Cu(I)/Cu(II)91,217,279 (Sch 3.2) or with alkyne present on dibenzo-cyclooctyne 
(DIBO) which is driven by the loss of ring strain. Because the phosphinate are 
susceptible to reaction with radicals280. We chose the aza-dibenzocyclooctyne 
(ADIBO) amine281 as heterobifunctional linker. On one side, DIBO is present to react 
with azide group on (43) and on the other side, a primary amine is present to react with 
the carboxylic acid moiety of PLGA. The linker was conjugated to the PLGA in the 
presence of DIC and NHS and the sensor was subsequently attached to the modified 
polymer in THF overnight (Sch. 3.3). All steps were monitored by FTIR, by following 
the appearance of the amide peaks when the linker is added (amide N-H stretch 
between 3500 – 3180 cm-1) and a very small increment of alkene peak (alkene C-H 
stretch between 3100-3000 cm-1) (Fig. 3.5). As previously, experimental data (like 
NMR or MS) can’t prove the conjugation of sensors to the polymer, but the polymer 

















Figure 3.5: Evolution of FTIR of formation of (43)-PLGA 
3.2. Synthesis of NPs 
Two robust approaches to obtaining polymeric nanoparticles are double and single 
emulsion depending on the aqueous solubility of the material to be encapsulated. 
PLGA is a suitable material to be used in either of these approaches. 
3.2.1. Single emulsion 
To obtain NPs, PLGA or the desired polymer-sensor conjugate was dissolved in DCM 
and added dropwise to an aqueous solution of PVA under sonication. The mixture was 
left stirring to evaporate the DCM and then centrifuged. The resulted pellet was 
separated from the supernatant and the NPs suspended in PBS (Fig. 3.6)277,283. PLGA 
particles with a hydrodynamic radius of 143.53 ± 2.27 nm, measured by dynamic light 





Figure 3.6: Single emulsion scheme 
3.2.2. Double emulsion 
The double emulsion technique is similar to the single emulsion with the only difference 
that a first emulsion of an aqueous PVA solution in the polymer solution is made. The 
first emulsion is prepared by slowly adding the PVA solution to a sonicating solution of 
DCM containing either PLGA. This water-in-oil emulsion is then added dropwise to an 
aqueous solution of PVA and stirred while the DCM evaporated. Thereafter the NPs 
are obtained and suspended in PBS as before284,285. Dynamic light scattering showed 
that this method afforded PLGA particles with an average hydrodynamic diameter of 
151.10 ± 3.11 nm. 
Both methods can be used to prepare NPs, suitable for cell penetration. The single 
emulsion has the advantage of being simpler and quicker whereas the double emulsion 
would be most suitable if there was a requirement to entrap a water-soluble molecule 
in the NPs. This is not required for this study, so, the single emulsion was chosen for 







1% PVA in water





Following the method described above, NPs were prepared using PLGA and PLGA-
conjugated with the different sensors to form nanosensors. The size and the zeta 
potential obtained for the different nanosensors are reported and compared with 
literature in Table 3.1.  
Table 3.1: Size and zeta potential of nanosensors 
Polymers Size (nm) Zeta (mV) 
PLGA single emulsion 143.53 ± 2.27 / 
PLGA double emulsion 151.10 ± 3.11 / 
PLGA single emulsion (literature)284,286 60-200 -29 ± 0.18 
PLGA double emulsion (literature)283,287 200 -23.3 ± 0.6 
PLGA (43) 149.63 ± 5.64 -2.08 ± 0.32 
PLGA (58) 155.83 ± 0.46 - 3.7 ± 0.78 
PLGA (72b) 144.6 ± 0.30 -2.29 ± 0.43 
 
The average hydrodynamic radius of the NPs obtained by single emulsion is consistent 
with the values reported in the literature, both when PLGA and PLGA conjugates are 
used. This can be explained considering that even in the case of polymer conjugates, 
the bulk of the nanoparticle is represented by PLGA, making it plausible that the minor 
component (the sensor) does not affect the formation and the properties of the particle. 
Zeta potential measures the surface charge of the molecule (Fig. 3.7). The zeta 
potential of PLGA NPs in literature is ca. -26 ± 0.15 mV286,287. The negative value is 




The sensor-containing NPs display less negative values of zeta potential, which can 
be explained by the fact that the carboxylic groups are shielded by the presence of the 
sensor molecule.  
   
Figure 3.7: Zeta potential graphic representation, from Julbe et al. 288 
3.2.4. Stability of NPs 
We next evaluated the stability of NPs in solution. This is an important parameter 
because the size of the NPs can increase due to irreversible aggregation and 
precipitation. NPs with small values of zeta-potential have a low surface charge, so 




repulsion between them. The stability of the NP suspensions was evaluated by storing 
the suspensions at room temperature and at 4 °C (in the fridge); the size and 
polydispersity of the NPs were monitored after one week, two weeks and a month. The 
behaviour of the size and polydispersity of nanosensors is shown in Fig 3.8 to 3.13. 
The values remain relatively stable for the time of the study, both at room temperature 
and at 4°C. Our NPs show a great stability after a month. In most of the samples (Fig 
3.8 – 3.13), an increase in the average hydrodynamic radius and polydispersity index 
is observed after 7 days. In literature, NPs of PLGA keep a constant size the 21st days 
in general289. Our data suggests the formation of aggregates, but the apparent 
reversibility of the process, evidenced by the decrease of hydrodynamic radius and 
polydispersity index in subsequent measurements, indicates that flocculation rather 
than irreversible aggregation occurred290. Those variations can be due to external 
parameters (e.g., atmospheric pressure, room temperature, humidity, etc.) or 
variations during sample handling (e.g., how the sample is stirred before data 
acquisition). Their size remained under 200 nm which is the highest limit for the EPR 
effect291 and their PdI stayed under 0.3 which is the highest limit too. EPR (i.e., 
enhanced permeability and retention) effect is a phenomenon caused by the altered 
microvasculature in tumour tissue that causes macromolecules and nanoparticles to 



















































Figure 3.9: Polydispersity index (PdI) stability of (43)-functionalised PLGA NPs (N = 
3) 














































Figure 3.11: PdI stability of (58)-functionalised PLGA NPs (N = 3) 














































Figure 3.13: PdI stability of (72b)-functionalised PLGA NPs (N = 3) 
3.2.5. Responsiveness of the nanosensors to ROS analytes 
Lastly, we undertook the preparation of nanosensors containing different fluorescent 
probes to evaluate the possibility of monitoring different ROS species independently 
by evaluating their response in the presence of different kinds of ROS. The first studies 
were carried out by exposing 1 mg/mL suspensions of NPs to the target ROS analyte, 
generated with the methods reported in Chapter 2 (paragraphs 1.2, 2.2 and 3.2). 
3.2.5.1. Superoxide-responsive nanoparticles 
The fluorescent emission of the (43)-functionalised nanoparticles in the presence of 
different amount of XO is reported in Figure 3.14. Firstly, we observed that the shape 
of the emission spectrum had changed. This phenomenon is not uncommon for 
sensors associated to a polymer and this behaviour has been previously described for 




(519 nm and 530 nm respectively). In our case, two peaks of emission are visible, one 
at 530 nm and the other at 545 nm. The presence of two relative emission maxima can 
be ascribed to the presence of two “populations” of fluorophores, one embedded in the 
NP and others on the outer surface of the particles103. We verified that the increase in 
the fluorescence intensity is limited but more marked than the one observed in the 
stand-alone sensor. It is known that associating sensors with nanoparticles can protect 
the fluorophore from degradation caused by the surrounding environment, as reported 
for PEBBLE nanosensors195,210. Moreover, the evolution is linear between 0 and 15 µL 
(Fig. 3.15). This last property is important to calibrate our measure and to calculate the 
amount of ROS when we know fluorescence level. 
























Figure 3.14: Example of fluorescence emission spectra of (43) on PLGA NPs in the 






















Y = 0.03103*X + 1.004
R² = 0,9974 
 
 
Figure 3.15: Intensity ratio for (43)-PLGA NPs with superoxide anion (data are 
normalised with blank experiment: sensor without ROS) 
When we assessed the selectivity of the sensor towards other ROS, we observed an 
increase in the fluorescence emission in the presence of hydrogen peroxide but no 
increase in the presence of singlet oxygen (Fig. 3.16 & 3.17). These results show that 






























Figure 3.16: Example of fluorescence emission spectra of (43) on PLGA NPs in the 
presence of hydrogen peroxide 























Figure 3.17: Example of fluorescence emission spectra of (43) on PLGA NPs in the 




3.2.5.2. Hydrogen peroxide-responsive nanoparticles 
As reported in Chapter 2 (part 2.2.2.), we observed an unexpected decrease of 
intensity of fluorescence emission of (58) in the presence of increasing amounts of 
hydrogen peroxide. For (58) PLGA NPs the same behaviour was observed (Fig. 3.18). 
In addition, the same behaviour is observed in response to superoxide radical anions 
and singlet oxygen (Fig. 3.19 & 3.20). On the bases of these results, we concluded 
that (58) is neither an efficient nor a selective sensor for ROS. 



























Figure 3.18: Example of fluorescence emission spectra of (58) on PLGA NPs in the 


























Figure 3.19: Example of fluorescence emission spectra of (58) on PLGA NPs in the 
presence of superoxide anion 
























Figure 3.20: Example of fluorescence emission spectra of (58) on PLGA NPs in the 




3.2.5.3. Singlet oxygen-responsive nanoparticles 
In Chapter 2 we described how (72b) showed the expected decrease of fluorescence 
intensity in the presence of singlet oxygen. The behaviour is maintained with (72b)-
PLGA conjugates, although the decrease is less pronounced (Fig. 3.21). As observed 



























Figure 3.21: Example of fluorescence emission spectra of (72b) on PLGA NPs in the 
presence of singlet oxygen 
Finally, (72b) show an interesting selectivity (Fig. 3.22 & 3.23): for low concentration 
of superoxide anion or hydrogen peroxide the intensity of emission is unaffected, 
whereas it starts to decrease at high concentration. This sensor is potentially useful to 
detect/quantify singlet oxygen, although the limited changes in the emission intensity 

























Figure 3.22: Example of fluorescence emission spectra of (72b) on PLGA NPs in the 
























Figure 3.23: Example of fluorescence emission spectra of (72b) on PLGA NPs in the 





3.2.6. Nanosensors containing (43) and (72b) 
Because of the encouraging responsive behaviour of (43)-PLGA NPs and (72b)-PLGA 
NPs with respectively superoxide anion and singlet oxygen reported in Chapter 3 
(paragraph 3.2.5.), we attempted to evaluate whether the independent monitoring of 
ROS species was possible using (43)- and (72b)-conjugated polymers. A first 
experiment was carried out on a suspension of (43)-PLGA NPs and (72b)-PLGA NPs. 
A second experiment was carried out preparing a batch of (43)-PLGA and (72b)-PLGA 
NPs. The behaviour of the samples in the presence of superoxide and singlet oxygen 
is reported in figures 3.24 and 3.25. 
3.2.6.1. Combination of the two batches of NPs 
Figure 56 shows the fluorescence intensity variation when (43) and (72b) NPs are in 
the presence of singlet oxygen. The behaviour of (43) on PLGA is unexpected under 
this condition with an observed increase of fluorescence while (72b) on PLGA 
demonstrates an expected evolution with a decrease of fluorescence. The unexpected 
variation of fluorescence of (43) is not easy to explain. Although the absorption and 
emission spectra of (72b) (Chapter 2 part 3.2) and (43) (Chapter 2 part 1.2) on PLGA 
partially overlap, the two sensors are not close enough to give rise to FRET effect, 






















Figure 3.24: (43) and (72b) NPs with singlet oxygen (N = 3) 
In the presence of superoxide radical anion (Fig. 57), the fluorescence intensity of (43) 
increases as expected, but a decrease of the intensity of (72b) fluorescence was also 
observed. Although the decrease is limited, it is of the same order as the one observed 
























Figure 3.25: (43) and (72b) NPs with superoxide (N = 3) 
3.2.6.2. Two sensors on the NPs 
In the presence of singlet oxygen (Fig. 3.26), the fluorescence intensity of (43) 
increases to a lesser extent compared to what we observed in the experiment reported 
above. The fluorescence of (72b) decreases as expected and more markedly. It should 
be noted, however, that the error bars in the graph are large, which make it difficult to 























Figure 3.26: (43) and (72b) in one pot with singlet oxygen (N = 3) 
The responsiveness of (43) and (72b) to superoxide anion are more promising than 
those obtained from the sample with the two populations of nanoparticles (Fig. 3.27). 
In the presence of superoxide radical anion, the intensity of the fluorescence of (43) 
increases while that of (72b) decrease only slightly at higher concentrations of 
superoxide, a similar behaviour was observed when (72b)-PLGA alone was exposed 
to superoxide. These results encouraged further experiments with dual NPs obtained 























Figure 3.27: (43) and (72b) in one pot with superoxide anion (N = 3) 
3.3. Comparison with commercial sensors 
The non-optimal or unexpected behaviour of the NPs obtained could derive from the 
use of ROS sensors synthesised for this purpose but perhaps underperforming 
compared to more robust commercially available sensors. To prove the concept of dual 
independent sensing of ROS we decided to synthesise batches of sensors entrapping 
commercially available sensors: HE for superoxide anion (1a), peroxy yellow (73) for 





Figure 3.28: Commercial dyes used 
3.3.1. Synthesis of nanosensors with commercially available sensors 
3.3.1.1. (15a) 
The synthesis of (15a)-containing nanosensors is reported in the literature using a 
polyacrylamide nanoparticle as the support133. For ease of comparison with our 
system, we synthesised PLGA nanoparticles containing (15a). Synthesis of (15a)-
functionalised PLGA was carried out as reported in part 3 (section 1.1) and the NPs 
were obtained by single emulsion as reported in section 2.1. 
3.3.1.2. (1a) and (73) 
Due to the lack of suitable functional groups, (1a)218 and (73)236 cannot be linked on 
PLGA so we decided to encapsulate the sensors into the PLGA NPs using the single 





3.3.1.3. Size, zeta potential and stability 
Tab. 3.2 shows that the presence of sensors results in an increase of the size of the 
NPs. For (15a)-PLGA the new size is ca. 165 nm, but the incorporation of (1a) and (73) 
causes a marked increase, giving batches of particles with an average hydrodynamic 
radius of ca. 220 nm. NPs of this size may not be as readily internalised in cells or 
distributed selectively to tumour tissue via the EPR effect.  
The stability and PdI of the sensor-encapsulating NPs were studied as reported in 
section 3 of this Chapter. The zeta potential of the NPs is negative with lower values 
for (1a)- and (73)-containing NPs probably because the non-covalent incorporation 
leaves carboxylate groups free.  
Table 3.2: Size and zeta potential of nanosensors with commercial sensors 
Polymers Size (nm) Zeta (mV) 
PLGA single emulsion 143.53 ± 2.27 / 
PLGA (15a) 164.93 ± 4.02 -1,24 ± 0.54 
PLGA (1a) 220.53 ± 5.72 -5.6 ± 1.41 
PLGA (73) 226.53 ± 6.43 -3.37 ± 1.36 
 
Figures 3.29 & 3.30 show that suspensions of (15a)-NPs are stable both at room 
temperature and at 4 C for up to 30 days, as the average hydrodynamic radius does 
not increase. The PdI is under 0.3 which means the dispersity is low and stays 
constant. A peak is still present after 7 days which can be due to the atmosphere 




























Figure 3.29: Size stability of (15a) PLGA NPs (N = 3) 



















Figure 3.30: PdI stability of (15a) PLGA NPs (N = 3) 
Figures 3.31 to 3.34 show evidence of aggregation for (1a)- and (73)-containing NPs 




NPs does not seem to vary with a definite trend. In both samples we observed a 
decrease of the average hydrodynamic radius after one week. This data suggests the 
formation of aggregates, but we observe a reversibility of the process, evidenced by 
the decrease of hydrodynamic radius and polydispersity index in subsequent 
measurements, indicates that flocculation rather than irreversible aggregation 
occurred290 as previously discussed in Chapter 3 (Part 3.2.3).  
The trend of the PdI supports what we observed for the size. The PdI index increases 
at room temperature but not at 4 C (Fig. 3.31 and 3.34).  












































Figure 3.32: PdI stability for (1a) PLGA NPs (N = 3) 
 















































Figure 3.34: PdI stability of (73) PLGA NPs (N = 3) 
3.3.2. Responsiveness to target analytes 
The responsiveness of the new NPs to target ROS analytes was studied following the 
approaches described in section 3.2.5, namely, exposing the functionalised 
nanoparticles to xanthine/xanthine oxidase, hydrogen peroxide and photodynamically 
generated singlet oxygen. 
3.3.2.1. Superoxide-responsive nanoparticles 
The recommended excitation wavelength for (1a) is 535 nm, which causes an intense 
emission at 610 nm3,104. Disappointingly, we did not obtain any fluorescence emission 
in these conditions. The only very minor emission peak was registered at 527 nm 
following excitation at 485 nm (Fig. 3.35). Interaction with the polymer clearly affected 
the emissive behaviour of (1a)293. A very minor increment of the intensity of this band 
was observed in the presence of superoxide, but this would not be useful to monitor 



























Figure 3.35: Example of fluorescence emission spectra of (1a) on PLGA NPs in the 
presence of superoxide 
Fig 3.36 and 3.37 show that the presence of peroxide does not alter the profile of the 
emission spectrum of (1a) in NPs but very minor alterations are observed in the 
presence of singlet oxygen. The emissive profile of (1a) in nanoparticles indicate that 


























Figure 3.36: Example of fluorescence emission spectra of (1a) on PLGA NPs in the 
presence of singlet oxygen 




















Figure 3.37: Example of fluorescence emission spectra of (1a) on PLGA NPs in the 





3.3.2.2. Hydrogen peroxide-responsive nanoparticles 
Unlike what we observed for (1a)-containing nanoparticle, (73) encapsulated in PLGA 
NPs maintains a similar behaviour with respect to excitation and emission as that 
described in the literature3. As expected, the fluorescence of (73) increases when it is 
exposed to hydrogen peroxide. Crucially, the fluorescence intensity reaches a 
maximum very quickly and the increase is not linear but asymptotic (Fig. 3.38 and 
3.39). The system was probably saturated and no more sensor was available to react 
with hydrogen peroxide. 






















Figure 3.38: Example of fluorescence emission spectra of (73) on PLGA NPs in the 















Figure 3.39: (73) PLGA with hydrogen peroxide (ratio versus the amount of 
hydrogen) (data are normalised with blank experiment: sensor without ROS) 
(73) in PLGA shows good selectivity, as exposure to superoxide and singlet oxygen 
do not cause the fluorescence intensity to increase (Fig 3.40 and 3.41). The small 
increment observed with superoxide anion can be explained by the fact that superoxide 
can turn into hydrogen peroxide and not enough catalase was available for the highest 

























Figure 3.40: Example of fluorescence emission spectra of (73) on PLGA NPs in the 
presence of singlet oxygen 





















Figure 3.41: Example of fluorescence emission spectra of (73) on PLGA NPs in the 




3.3.2.3. Singlet oxygen-responsive nanoparticles 
Compared to free (15a) with excitation at 505 nm and emission at 525 nm63 or 
nano(15a) with excitation at 420 nm and emission at 525 nm133, (15a) on PLGA NPs 
has an excitation at 474 nm and an emission at 540 nm. That means the PLGA has an 
influence on the emissive behaviour of the sensor. With singlet oxygen (Fig. 3.42), 
(15a) shows good responses as it was expected. The fluorescence intensity increase 
shows a good linearity, which could be useful to quantify singlet oxygen in the range 


























Figure 3.42: Example of fluorescence emission spectra of (15a) on PLGA NPs in the 
















Y = 0.01273*X + 1.333
R² = 0.9588
  
Figure 3.43: Linear regression of ratio of (15a) PLGA (data are normalised with blank 
experiment: sensor without ROS) 
Unfortunately, in the presence of superoxide radical anion, (15a) displays an increase 
of fluorescence intensity, but to a lesser extent than in the presence of singlet oxygen 
(Fig. 3.44). No increase of intensity of emission was observed in the presence of 
hydrogen peroxide, indicating a promising, if partial, selectivity of response to the target 


























Figure 3.44: Example of fluorescence emission spectra of (15a) on PLGA NPs in the 

























Figure 3.45: Example of fluorescence emission spectra of (15a) on PLGA NPs in the 




3.3.2.4. Evaluation of individual responses in a nanosensors mixture 
The inability to covalently link (1a) and (73) to PLGA posed a challenge to the synthesis 
of dual sensors, via the strategy we previously adopted and described in section 3.3. 
This encouraged us to explore the responsiveness and the selectivity of the individual 
sensors as a mixture. Samples were prepared containing comparable amounts of 
nanosensors of each type ((15a)-PLGA, (1a)-PLGA, (73)-PLGA). Each sample was 
exposed to one particular ROS and the fluorescence of the three sensors was 
recorded. The ROS were generated according to the methods previously described 
(section 3.2).  
The results of the experiment show that the performance of the single sensors 
decrease in the presence of other sensors (Fig. 3.46). Some of the selectivity observed 
with single sensors was lost and the responsiveness decreased. In short, we could not 
observe the target simultaneous and independent monitoring of ROS as we hoped. 
We speculate that in some cases interference may occur between the 
















































































































































(15a) PLGA with singlet oxygen
(15a) PLGA with hydrogen peroxide
(15a) PLGA with superoxide
(1a) PLGA with singlet oxygen
(1a) PLGA with hydrogen peroxide
(1a) PLGA with superoxide
(73) PLGA with singlet oxygen
(73) PLGA with hydrogen peroxide
(73) PLGA with superoxide
 
Blank: sample not exposed to ROS.
1st measurement: 30 second irradiation for singlet oxygen
   245 nmol of hydrogen peroxide solution for peroxide
                        10 µL of XO for superoxide
2nd measurement: 60 second irradiation for singlet oxygen
    490 nmol of hydrogen peroxide solution for peroxide
                          20 µL of XO for superoxide
 
Figure 3.46: Results for commercial sensors on PLGA mixture with ROS (N = 1) 
3.4. Overview of the behaviour of the nanosensors 
In this section we intend to provide an overview of the behaviour of all the nanosensors 
generated in this work towards the different ROS analytes. 
3.4.1. Response to superoxide radical anion 
In the presence of superoxide anion (Fig. 3.47), (43)-PLGA and (15a)-PLGA increase 
their fluorescence, while (1a)-PLGA and (73)-PLGA are stable and (58)-PLGA an 
(72b)-PLGA slightly decrease. The behaviour of (15a) (fluorescence intensity should 




increment of (43) nanosensors is linear in this range of experiments, that means it is 
possible to quantify superoxide with this nanosensor. 



































Figure 3.47: Nanosensors reactivity with superoxide anion (emission signals are 
normalised with blank experiment: sensor without ROS) 
3.4.2. Hydrogen peroxide 
In the presence of hydrogen peroxide (Fig. 3.48), the fluorescence emission of (73) 
NPs increase until it reaches a maximum, while (58) NPs show an unexpected 
decrease of fluorescence emission. The other nanosensors show the expected stability 








































Figure 3.48: Nanosensors reactivity with hydrogen peroxide (emission signals are 
normalised with blank experiment: sensor without ROS) 
3.4.3. Singlet oxygen  
In the presence of singlet oxygen, (15a)-containing nanosensors show the expected 
increase of fluorescence emission (Fig. 3.49) (72b)-nanosensors show a decrease in 
fluorescence emission, as expected, but too limited to be useful in monitoring this 
analyte. The remaining nanosensors show lack of responsiveness to singlet oxygen, 
as their fluorescence intensity is unvaried. (1a)-PLGA displays a minor increase for 





Figure 3.49: Nanosensors reactivity with singlet oxygen (emission signals are 
normalised with blank experiment: sensor without ROS) 
3.5. Chapter conclusion 
We obtained three target conjugates with our new sensors: (43)-PLGA, (58)-PLGA and 
(72b)-PLGA. By using the single emulsion method, stable nanosensors were obtained. 
The fluorescent behaviour the nanosensors are similar to those of the corresponding 
stand-alone probe and PLGA conjugate. A comparison of the response of the 




containing encapsulated commercial probes (i.e., (1a), (15a) and (73)) showed 
interesting results. 
Because of its linear response to superoxide anion and its good stability to the other 
ROS, (43)-PLGA is a good nanosensor for superoxide anion in comparison with (1a)-
PLGA.  
Because of its response to hydrogen peroxide and stability to various ROS, (73)-PLGA 
showed a more favourable behaviour as a sensor for hydrogen peroxide. One of its 
limitation is the lack of linearity for the quantification. (58)-PLGA showed an 
unexpected behaviour that does not encourage its use as a hydrogen peroxide sensor.  
Lastly, (15a)-PLGA is a more promising sensor compared to (72b)-PLGA for singlet 
oxygen because of its higher sensitivity and linearity of answer, which gives the 
possibility to quantify ROS. The low stability of both singlet oxygen sensors towards 












Chapter 4. Cell studies 
The species displaying the most promising behaviour in solution were studied as 
intracellular nanosensors. (43), (15a) or (73) responded as expected in the presence 
of superoxide, singlet oxygen and hydrogen peroxide, respectively. In this part, we 
report the results of our studies on the responsiveness of the sensors in the presence 
of subcellular components and biomacromolecules in order to assess the applicability 
of the nanosensors within cell. We focused on the ability of the nanosensors to enter 
cells, on their toxicity and efficiency as ROS sensors. The response of the nanosensors 
was compared with the response of the stand-alone sensors.  
To study the responsiveness of sensors in cells, the choice of the cell line is crucial. 
THP1 is a monocytic cell line derived from leukaemia that is often used as in vitro 
cancer cell models and as representative of monocytes and macrophage immune 
cells296–298. The reactivity of THP1 with ROS to study the monocyte-macrophage 
differentiation298 or apoptosis297 makes this cell line a good candidate to study the 
responsiveness of our sensors. 
ROS were generated by the addition of phorbol-12-myris-tate-13-acetate (PMA). PMA 
induces cell differentiation at a range from 20 ng/mL299, which is a particular kind of 
cellular division that produces more specialised types of cells, by inducing oxidative 
stress298,300–302. Firstly, superoxide radical anion is generated and then other ROS as 
hydrogen peroxide are produced thanks to SOD present in cells (Chapter 1. Fig. 1.3). 
The extent of superoxide formation with PMA depends on the concentration and time 
of exposure. For example, cells exposed at more than 50 ng/mL for 3–4 days results 
in significant cell death, in contrary, cells differentiated in 20 ng/mL of PMA were more 




procedure is the fact that it does not allow us to differentiate between superoxide or 
hydrogen peroxide because PMA will generate both. 
High levels of singlet oxygen are not produced in the homeostatic conditions in the 
cells, so photosensitisers must be used to increase the levels of this ROS59,303. In this 
part of the work we used the water-soluble porphyrin photosensitiser described in 
Chapters 2 and 3. Following incubation with the sensors and the photosensitiser, cells 
were exposed to blue light (400 nm) for the generation of singlet oxygen. 
4.1. Flow cytometry 
Flow cytometry304 measures optical and fluorescent characteristics of single cells. 
Physical properties, such as size (represented by forward angle light scatter (FSC-A)) 
and cytoplasmic complexity (i.e. granularity) (represented by right-angle scatter (SSC-
A)) can resolve certain cell populations by autofluorescence. Flow cytometry can also 
evaluate the fluorescence of labelled cells. 
Inside a flow cytometer, cells in suspension are drawn by a stream that allow the cells 
to pass individually through an interrogation point. At the interrogation point, a beam of 
monochromatic light, usually from a laser (488 nm, in our case), intersects the cells. 
Light is scattered off in all directions and is collected via optics that direct it to a series 
of filters (four filters are present on flow cytometer: 533/30, 585/40, 670LP and 675/25 
nm). The light signals are then detected by photomultiplier tubes and digitized for 





Figure 4.1: Overview of the flow cytometer 
The distribution of THP1 population on a flow cytogram is clear with area for apoptotic 
and viable cells (Fig. 4.2). Because of their smaller size due to their shrinking and to 
the formation of blebs and the fragmentation of organelles during the apoptosis305, 
apoptotic cells are on the left side of the graph while viable cells stay at the bottom 
because of their bigger size and their lack of many fragmented organelles. This 
separation between both kind of cells and their distribution can give us an idea of the 




We can see on figure 4.2 that apoptotic (in the left box) cells with all fragments are 
more complex (represented on SSC-A), than the viable cells (in the right box). 
Moreover, sizes (represented on FSC-A) are more important for viable cells than 
apoptotic one. Finally, viable cells are more represented with 91.2 % of them compared 
to 7.1 % for apoptotic cells. 
 
Figure 4.2: THP1 cells distribution 
4.2. Microscopy 
Flow cytometry is a method to quantify the fluorescence associated to a single cell, but 
it does not give any information about whether the fluorophore is inside the cell or about 
its intracellular localisation. The most suitable technique to obtain this kind of 
information is fluorescence microscopy. 
Similar to the widefield microscope, the confocal microscope uses fluorescence 




a defined spot at a specific depth within the sample. This leads to the emission of 
fluorescent light at exactly this point. A pinhole inside the optical pathway cuts off 
signals that are out of focus, thus allowing only the fluorescence signals from the 
illuminated spot to enter the light detector (Fig. 4.3). 
 
 
Figure 4.3: Confocal microscope principle 
By scanning the specimen in a raster pattern, images of one single optical plane are 
created. 3D objects can be visualized by scanning several optical planes and stacking 
them using a suitable microscopy deconvolution software (z-stack). This last option 




4.3. Incubation time 
To determine the optimal incubation time for maximum sensor internalisation and 
minimal damage to cells, THP1 were incubated with nanosensors solution at 1 mg/mL 
in PBS at different time at 37 °C with 5% of CO2. Cell solutions were analysed by flow 
cytometry by following the evolution of the fluorescence. The incubation of sensors on 
PLGA is quick and after 30 min cells are mostly at their maximum signal (Fig. 4.4). This 
time was chosen for the rest of the studies. 




























Figure 4.4: Determination of incubation time of sensors on PLGA 
4.4. Cell internalisation of the sensors 
To prepare cells for confocal microscopy, the literature encourages us to fixe THP1 
cells to maintain cellular structure307,308. PMA is an agent that can induce ROS 
production and the cell differentiation generated is useful to fix cellular structure302,309. 
The cells were differentiated and exposed to a solution containing nanosensors and 




and examined on the confocal microscope (see experimental part). Parameters of 
microscope for the next figures are the same and described in the experimental part.  
(43)-PLGA or stand-alone (43) were both observed to penetrate into the cells (Fig. 4.5), 
and the z-stack analysis shows that the sensors are inside the cell. 
 
Figure 4.5: Confocal microscopy pictures of THP1 incubated with (43) (1) and with 
(43)-PLGA (2). A) sensor fluorescence; B) white field; C) superposition of A and B; D) 
sensor fluorescence at different focal plans (0 µm, 2.3 µm, 4.6 µm, 6.9 µm, 9.2 µm, 




As above, both stand-alone (58) and (58)-PLGA NPs penetrate the cells (Fig. 4.6). No 
measurable difference was observed between the internalisation behaviour of sensors 
whether they are associated or not to PLGA NPs. 
 
Figure 4.6: Confocal microscopy pictures of THP1 incubated with (58) (1) and with 
(58)-PLGA (2). A) sensor fluorescence; B) white field; C) superposition of A and B; D) 
sensor fluorescence at different focal plans (0 µm, 2.3 µm, 4.6 µm, 6.9 µm, 9.2 µm, 




Similarly, both NPs-conjugated and stand-alone (15a) are able to penetrate the cells 
(Fig. 4.7). The internalisation of stand-alone sensor seems more efficient than the 
corresponding NPs-supported sensor. Some brighter spots seem to indicate that the 
localisation of the nanosensors in the cells is restricted to certain compartments. A 
deeper characterization should be useful to show where sensors are accumulated by 
referencing the differencing the different organelles withs labels. 
 
Figure 4.7: Confocal microscopy pictures of THP1 incubated with (15a) (1) and with 
(15a)-PLGA (2). A) sensor fluorescence; B) white field; C) superposition of A and B; 
D) sensor fluorescence at different focal plans (0 µm, 2.3 µm, 4.6 µm, 6.9 µm, 9.2 




As above, (1a) proves able to penetrate cells both as stand-alone sensor and 
associated to NPs (Fig. 4.8). In this case, the nanosensors seem to be internalised 
more efficiently.  
 
Figure 4.8: Confocal microscopy pictures of THP1 incubated with (1a) (1) and with 
(1a)-PLGA (2). A) sensor fluorescence; B) white field; C) superposition of A and B; D) 
the location of sensor at different local plan (0 µm, 2.3 µm, 4.6 µm, 6.9 µm, 9.2 µm, 




Finally, for (73), we can observe that the internalisation is achieved when the sensor 
is free (Fig. 4.9(1)). (73)-PLGA NPs are internalised but they seem to localise only in 
some organelles (Fig. 4.9(2)) but as for (15a) a deeper investigation should help for 
this interpretation and to be precise.  
 
Figure 4.9: Confocal microscopy pictures of THP1 incubated with (73) (1) and with 
(73)-PLGA (2). A) sensor fluorescence; B) white field; C) superposition of A and B; D) 
sensor fluorescence at different focal plans (0 µm, 2.3 µm, 4.6 µm, 6.9 µm, 9.2 µm, 





We next investigated the effect of the sensors on cell viability. The cytotoxicity of the 
stand-alone sensors and of the nanosensors was evaluated. 
To this end, 100 µL TPH-1 cells were incubated with NPs or stand-alone sensors over 
a volume range of 0 to 200 µL of solution at 1 mg/mL in PBS. Although the addition of 
sensor solution will dilute the cells in the sample, this will not affect the outcome of the 
experiment because flow cytometer counts the number of cells regardless of the 
sample concentration. The viability of cells was evaluated by flow cytometry by 
analysing the distribution between viable cells (P4) and apoptotic cells (P5) given on 





Figure 4.10: Example of distribution to analyse cytotoxicity of PLGA on THP1 cells 
 
First, the effect of PLGA alone is on cell viability was assessed. Cell viability remained 
constant as the concentration of polymer increased (Fig. 4.11) and PLGA was not 

























Figure 4.11: Cytotoxicity of PLGA (N = 3) 
As shown in Figures 4.12 to 4.16, the percentage of viable cells is constant both in the 
presence of stand-alone sensors and PLGA-sensor NPs, thus demonstrating the low 



























Figure 4.12: Cytotoxicity of (43) (stand-alone sensor and nanosensors) (N = 3) 
















































Figure 4.14: Cytotoxicity of (15a) (stand-alone sensor and nanosensors) (N = 3) 
















































Figure 4.16: Cytotoxicity of (73) (stand-alone sensor and nanosensors) (N = 3) 
We have compared the density of all cells with apoptotic cells, represented by the 
number of events per volume injected to see if this value is constant. As shown of the 
fig 4.17, this value is decreasing in all case and in the same way. This behaviour can 
be explained by cell death following a necrosis pathway. But in our case, PLGA has 
the same behaviour than our probes. That can be due to the limit of our method and 
the dilution of the sample. To see this kind of toxicity, it is important to keep the same 









































Figure 4.17 Cell density through flow cytometer depending on the addition  
4.6. Responsiveness of sensors in cells depending on PMA exposure time 
PMA induced cell differentiation by generating superoxide. Superoxide is transformed 
into hydrogen peroxide by SOD presents in cell. This study described in this section 
aimed to investigate the dependence of sensor response in cells on time of exposure 
to those two ROS.  
THP1 cells were incubated with the different sensors at 1 mg/mL in PBS for 30 min 
and then exposed to a fixed amount of PMA at 2.5 µM for different lengths of time. The 
changes in the fluorescence emission between 533 nm and 630 nm were monitored 
by flow cytometry302. All data are rationalised with values of cells with same 




Figure 4.18 shows the increase of fluorescence intensity over time for cells containing 
stand-alone (43) and (43) nanosensors which is the expected behaviour because PMA 
induced superoxide anion. (43)-PLGA fluorescence increases quickly for 5-10 min and 
then it increases slowly probably because of the consumption of sensors is close to be 
complete. For stand-alone (43), the increment is less important at the beginning, 
probably because of a lake of stability in front of some enzyme as observed in chapter 
2 (section 2.1.2.2.). 
 

































Figure 4.18: Fluorescence evolution for (43) (stand-alone sensor and nanosensors) 
in THP1 cells with PMA-induced ROS generation over time (N = 3) 
Figure 4.19 shows the increase of fluorescence during 10 min for cells containing 
stand-alone (58) and (58) nanosensors which is the expected behaviour. Then, we can 
observe that stand-alone (58) increases slowly and (58)-PLGA decreases a bit due to 
the consumption of sensors less present in NPs. Both are following a similar curve for 
their increment. Importantly, in these experiments, in contrast with the behaviour 
displayed by (58) sensor in solution, the expected increase of fluorescence intensity 




can be due to some enzymes presents in cells or in the media that can stabilized our 
sensor. 

































Figure 4.19: Fluorescence evolution of (58) (stand-alone sensor and nanosensors) in 
THP1 cells with PMA-induced ROS generation over time (N = 3)  
Fig 4.20 shows that stand-alone (15a) has an unexpected behaviour with a high 
increment at the beginning while normally (15a) has to react only with singlet oxygen. 
Exposure of (15a) nanosensors containing cells with PMA does not lead to 
fluorescence variations as expected (Fig. 4.20). The use of NPs for (15a) is very 




































Figure 4.20: Fluorescence evolution of (15a) (stand-alone sensor and nanosensors) 
in THP1 cells with PMA-induced ROS generation over time (N = 3) 
Figure 4.21 shows that stand-alone (1a) and (1a)-PLGA have an expecting increment 
when this sensor is exposed to superoxide anion. Moreover, they look like linear if (1a) 
is stand alone or in NPs. Because (1a) is not attached on PLGA but just encapsulated, 
seeing the same behaviour is understandable because the structure of (1a) is not 
affected. Same observations can be made on (73) and (73)-PLGA on figure 4.22 with 




































Figure 4.21: Fluorescence evolution of (1a) (stand-alone sensor and nanosensors) in 
THP1 cells with PMA-induced ROS generation over time (N = 3) 
 































Figure 4.22: Fluorescence evolution of (73) (stand-alone sensor and nanosensors) in 
THP1 cells with PMA-induced ROS generation over time (N = 3) 
To summarize, all sensors except stand-alone (15a) display the expected behaviour in 
the presence of ROS: (43), (58), (1a) and (73) show an increase of fluorescence in the 




(58), (1a), and (73) show a similar behaviour either is stand-alone or NPs form. For 
(43) and (15a), better responses are observed when they are under NPs form. One of 
the limits of this method is that we cannot estimate the level of hydrogen peroxide and 
of superoxide because both are linked. So, there is not proof if (43) and (1a) reacts 
only with superoxide and (58) and (73) only with hydrogen peroxide. 
4.7. Responsiveness of sensors in cells depending on PMA concentration 
To confirm our results, we wanted to see if the differentiation induced by PMA has an 
impact on the fluorescence results. To try and establish the effect of differentiation, we 
studied the fluorescence response in function of the PMA concentration.  
THP1 cells were incubated with sensors solution at 1 mg/mL in PBS for 30 min and 
exposed to different amounts of PMA solution at 2.5 µM for further 30 min. The 
changes in the fluorescence emission between 533 nm and 630 nm were monitored 
by flow cytometry302. 
As previously observed and as expected (Fig. 4.23 to 4.26), (43), (58), (1a) and (73) 
has an increment of fluorescence. (43) is better when it is under NPs form because 
PLGA protects it from enzymes, while (58) is better without because it is stabilized by 
enzymes. (1a) and (73) has similar behaviour if it is stand-alone or under NPs form. 




































Figure 4.23: Concentration dependent fluorescence evolution of (43) (molecular 
sensor and nanosensors) in THP1 cells following PMA-induced ROS generation (N = 
3) 

































Figure 4.24: Concentration dependent fluorescence evolution of (58) (molecular 




































Figure 4.25: Concentration dependent fluorescence evolution of (1a) (molecular 
sensor and nanosensors) in THP1 cells following PMA-induced ROS generation (N = 
3) 































Figure 4.26: Concentration dependent fluorescence evolution of (73) (molecular 





We observed a normal behaviour for (15a) with a stable fluorescence over PMA 
concentration because (15a) is not sensible with superoxide and hydrogen peroxide 
generated (Fig. 4.27). (15a) associated on PLGA is more stable than stand-alone one. 

































Figure 4.27: Concentration dependent fluorescence evolution of (15a) (molecular 
sensor and nanosensors) in THP1 cells following PMA-induced ROS generation (N = 
3) 
4.8. Responsiveness of sensors in cells with singlet oxygen 
The intracellular generation of singlet oxygen is achieved by incubation of the cells with 
solution of sensors at 1 mg/mL in PBS and a photosensitiser. Cells are irradiated with 
blue light for different times (from 10 to 60 sec) and are analysed by flow cytometry. In 
these experiments, the induced differentiation of the cells will not be an element 
affecting the response of the cell population, but because of the potential of causing 
photodynamic cell killing, more cells will appear as apoptotic and they will appear in a 




As shown on figure 4.28 to 4.31, a decrement is observed on (43), (58), (1a) and (73) 
(stand-alone or NPs). This is probably due to the bleaching of sensors under room or 
blue light. This phenomenon is more pronounced on (58)-PLGA. As shown in chapter 
2, (58) does not have the expected behaviour in PBS solution but in chapter 4, we have 
seen that (58) has the expected behaviour. Probably, this molecule is stabilized with 
enzymes and this property is less visible when (58) is attached on PLGA. Future work 
could be interesting to determine which enzymes stabilize (58) by adding in them in 
PBS separately. 































Figure 4.28: Fluorescence evolution of (43) (molecular sensor and nanosensors) in 


































Figure 4.29: Fluorescence evolution of (58) (molecular sensor and nanosensors) in 
THP1 cells following exposure singlet oxygen (N = 3) 
































Figure 4.30: Fluorescence evolution of (1a) (molecular sensor and nanosensors) in 




































Figure 4.31: Fluorescence evolution of (73) (molecular sensor and nanosensors) in 
THP1 cells following exposure singlet oxygen (N = 3) 
 
(15a)-based sensors respond as expected to singlet oxygen with an increase of 
fluorescence intensity. The behaviour is shown in figure 4.32, where it appears that 
(15a) give a more intense response as a stand-alone sensor than when incorporated 
in the nanosensors. The (15a)-PLGA nanosensors display a better increment of 



































Figure 4.32: Fluorescence evolution of (15a) (stand-alone sensor and nanosensors) 
in THP1 cells following exposure singlet oxygen (N = 3) 
4.9. Chapter conclusion 
All sensors and nanosensors responded to changing levels of intracellular ROS by 
increasing their fluorescence emission. Preliminary experiments confirmed that the 
sensors and nanosensors are not toxic to THP1 cells in the concentrations used in this 
work. In the case of (43), limited toxicity is observed at high concentrations of the stand-
alone sensor, but this is not observed with the nanosensors. (43)-PLGA shows great 
potential to determine level of ROS in cells, unfortunately, we cannot determine its 
efficiency between superoxide or hydrogen peroxide because both are present inside 
cells. In the experiments described in this section, (58) demonstrated good potential 
as hydrogen peroxide sensor, despite its unpromising behaviour observed in PBS, with 
a good response to ROS in cells and a good selectivity against singlet oxygen. Its 
response is better when (58) is stand-alone, that is probably due to enzyme 




(73) which are not conjugated to PLGA, no major differences are observed between 





















General conclusion and perspective of future work 
In this study, a number of sensors for different ROS have been synthesised. The aim 
was to obtain sensors bearing a conjugatable function to allow covalent anchoring to 
polymers to obtain nanosensors. We obtained three new target sensors by multi-steps 
synthesis: (43) for superoxide radical anion, (58) for hydrogen peroxide and (72b) for 
singlet oxygen.  
The behaviour of the sensors in the presence of the target analytes was studied. 
Despite some limitations (e.g., (43) suffered from instability in solution and an 
unexpected decrease in the fluorescence intensity of (58) following exposure to 
hydrogen peroxide), the sensors responded with fluorescence variations to ROS. (43) 
and (72b) showed a great potential to be sensors for superoxide and singlet oxygen. 
As previously reported by the Nagano group, minor modification of the molecular 
structure of the sensor can result in a drastic alteration of its responsiveness and 
selectivity147, which we observed for (43) and (58). 
PLGA conjugates of the sensors were obtained and a library of corresponding 
nanoparticles was prepared by single emulsion-based methods. The species were 
uniform in size and we confirmed that the presence of the polymer did not alter the 
responsiveness of the sensors to the ROS analytes. In particular we observed a 
promising responsiveness from the (43) nanosensors. The unexpected decrease of 
fluorescence of the (58) in the presence of hydrogen peroxide was maintained on the 
nanosensors. (72b) responded to singlet oxygen but the intrinsic loss of fluorescence 
in the presence of the target analyte makes it a “switch-off” sensor, which we 




Although we obtained nanoparticles containing two different sensors ((43) and (72b)), 
we verified that their fluorescence signals in response to the different analytes suffered 
from interference, thereby limiting their use. Other nanospecies were prepared, 
containing combinations of commercially available sensors; due to the lack of suitable 
functional group, the commercial sensors were encapsulated in the particles rather 
than conjugated to the polymer. 
To compare those results, the same study was performed with (15a) for singlet oxygen, 
(1a) for superoxide anion and (73) hydrogen peroxide. While (15a) was linked to PLGA 
NPs, (1a) and (73) were simply encapsulated in NPs. Although the response to the 
target analyte was as expected, we observed a lack of selectivity and, importantly, of 
interference between the signals. 
The behaviour of the stand-alone sensors and the NPs was characterised in THP1 
cells. Crucially, (58) displayed an increase of fluorescence intensity emission, which is 
the expected behaviour but in contrast to what we observed in solution. (43) 
nanosensors, on the contrary, gave a more intense response than the stand-alone 
(43). 
The choice of the nanosensor matrix is important because the polymer must not be 
toxic and not interfere with the light absorption/emission. The approach to generate 
intracellular ROS also needs to be carefully chosen: the method used in this work had 
the potential to interfere with the analysis by inducing cell differentiation and division. 
This work confirms the suitability of luminescent nanosensors for the intracellular 
monitoring of ROS. Our results show that if nanosensors containing more than one 











Reagents were purchased from Fluorochem, Sigma Aldrich, Fischer Scientific or 
Tokyo Chemical Industries, and were used as received unless otherwise specified. 
(78) have been provided by Dr Giuntini’s group. All solvents, either analytical or HPLC 
grade, were purchased from Fisher Scientific and used as received, unless otherwise 
specified. TLC analysis was performed using Fluorochem Silica Gel 60Å, 20X20 cm, 
F254 plates. Silica gel chromatography was performed employing silica gel 60 Å 
purchased from Fluorochem. Mass spectrometer analyses were performed on a 
Waters Micromass LCT equipped with an electrospray ionization (ESI) source and time 
of flight (ToF) detector. HPLC analyses were performed on a Waters separations 
module 2695. The separations were performed on a Gemini C18, 5 µm, 150x4.6 mm, 
110 Å (Phenomenex, UK) at a flow rate of 0.8 mL/min. Method employed depending 
on the nature of the compound. Method: the mobile phase consisted of water (solvent 
A) and acetonitrile (solvent B). Gradient: 0-2 min, 5% B; 2-18 min, 5-95% B; 18-21 min, 
95% B; 21-22 min, 95-5% B, 22-28 min 5%B. NMR analyses were performed 
employing either a Bruker 300 MHz (operating at 300.18 MHz for 1H and 75.48 MHz 
for 13C) or a Bruker 600 MHz (operating at 600.3 1MHz for 1H and 150.95 MHz for 
13C) spectrometers. CDCl3, DMSO-d6, CD3OD, and D2O were purchased either from 
Sigma-Aldrich or Fluorochem. CDCl3, CD3OD and D2O were employed as received, 
DMSO-d6 was dried over 3Å molecular sieves and stored under argon. Chemical shifts 
were reported in ppm, referenced to either CHCl3 (1H, 7.26 ppm; 13C, 77.16 ppm), 
DMSO (1H, 2.50 ppm; 13C, 39.52 ppm), MeOH (1H, 3.31 ppm; 13C 49.00 ppm) or 
D2O (1H, 4.79 ppm). Coupling constants (J) were reported in Hertz (Hz) and significant 




doublets (dd), doublet of triplets (dt), triplet of doublets (td), multiplet (m), broad singlet 
(bs) or broad (br). Fluorescence analyses in solution were performed employing a 
Varian Cary Eclipse Fluorescence Spectrometer. NPs size and zeta potential were 
performed on Zetasizer Nano-ZS. Cell culture were a kind gift of Dr Sexton’s research 
group at Liverpool John Moores University, and were obtained by growing THP1 in 
RPMI1640 medium310. Flow cytometry analysis were performed on a BD Accuri C6 
flow cytometer. Transmittance FTIR spectra were obtained on an Agilent Cary 630 
FTIR (Agilent Technology, UK). Confocal microscopy was performed on a Zeiss LSM 
700. Centrifugation was performed by Hermle Z400 and a C0383-75 rotor for speed 
under than 1,000 rpm or by Beckman Coulter Optima XPN-80 with a 70.1 Ti fixed-














Synthesis of di-tert-butyl (6-phenylphenanthridine-3,8-diyl)dicarbamate (25)  
 
6-phenyl-5,6-dihydrophenanthridine-3,8-diamine (484 mg, 1.70 mmol) was added to 
saturated aqueous sodium carbonate aqueous solution (10 mL) in a round bottom 
flask. A solution of di-tert-butyldicarbonate (2.6 g, 11.90 mmol) in the minimum volume 
of tetrahydrofuran was added dropwise at 0 °C. The solution was stirred and allowed 
to reach room temperature overnight. Tetrahydrofuran was evaporated at reduced 
pressure and the resulting mixture was extracted with ethyl acetate. The organic phase 
was dried on magnesium sulfate and ethyl acetate was evaporated at reduced 
pressure to give 562 mg (1.16 mmol) of a red brown solid. (69%).  
1H NMR (300 MHz, CDCl3) δ 8.54 (d, J = 9.0 Hz, 1H), 8.45 (d, J = 8.9 Hz, 1H), 8.13 (d, 
J = 8.7 Hz, 1H), 7.95 (dd, J = 10.1, 5.6 Hz, 2H), 7.73 – 7.66 (m, 3H), 7.52 (t, J = 6.7 
Hz, 3H), 6.73 (s, 1H), 6.67 (s, 1H), 1.56 (s, 9H), 1.50 (s, 9H). 
13C NMR (75 MHz, DMSO) δ 160.8, 153.4, 143.9, 140.2, 138.8, 130.2, 129.2, 128.8, 
124.9, 123.6, 123.4, 123.1, 119.6, 118.9, 117.0, 115.6, 79.9, 28.8, 28.7. 
ESI-MS (+ve): 486.4585 [M+H+] (C29H32N3O4+ requires 486.2387). 






Synthesis of 2-(2-(2-iodoethoxy)ethoxy)ethan-1-ol (30)  
 
2-(2-(2-chloroethoxy)ethoxy)ethan-1-ol (500 µL, 3.44 mmol) was added to 10 mL of 
acetone containing sodium iodide (1.03 g, 6.88 mmol) in a round bottom flask equipped 
with a reflux condenser. The mixture refluxed overnight, then it was allowed to cool to 
room temperature and filtered through cotton wool. The solvent was evaporated under 
reduced pressure, the residue was taken in 5 mL of distilled water and extracted with 
diethyl ether (10 mL). The organic phase was dried on magnesium sulfate and the 
solvent was evaporated under reduced pressure to give 633 mg (2.43 mmol) of a red 
brown solid (71%).  
1H NMR (300 MHz, CDCl3) δ 3.72-3.68 (m, 4H), 3.62-3.59 (m, 4H), 3.57-3.55 (m, 2H), 
3.23-3.19 (m, 2H). 
ESI-MS (+ve): 260.9898 [M+H+] (C6H14IO3+ requires 260.9909). 










Synthesis of 2-(2-(2-azidoethoxy)ethoxy)ethan-1-ol (31)  
 
2-(2-(2-iodoethoxy)ethoxy)ethan-1-ol (1.2 mg, 4.8 mmol) and sodium azide (940 mg, 
14.4 mmol) were dissolved in dry Acetonitrile (5 mL) in a round bottom flask equipped 
with a reflux condenser. After 2 days of reflux, the mixture was allowed to cool at room 
temperature and filtered through cotton wool. The solvent was evaporated under 
reduced pressure. The residue was taken deionised water (5 mL) and extracted with 
diethyl ether (10 mL). The organic phase was dried on magnesium sulfate and the 
solvent was evaporated under reduced pressure to give 629 mg (3.6 mmol) of a red 
brown solid (74%).  
1H NMR (300 MHz, CDCl3) δ 3.73-3.64 (m, 8H), 3.59 (t, J = 4.5 Hz, 2H), 3.38 (t, J = 
5.0 Hz, 2H).  
13C NMR (75 MHz, CDCl3) δ 72.3, 70.2, 70.0, 69.6, 61.1, 50.3. 
ESI-MS (+ve): 175.1111 [M+H+] (C6H15N4O2+ requires 175.1099). 









Synthesis 1-azido-2-(2-(2-chloroethoxy)ethoxy)ethane (33)  
 
2-(2-(2-chloroethoxy)ethoxy)ethan-1-ol (2 mL, 13.76 mmol) was dissolved in dry 
toluene (10 mL) under argon at 0°C in a round bottom flask equipped with a reflux 
condenser. MsCl (2.1 mL, 15.14 mmol) was added dropwise followed by TEA (1.3 mL, 
16.51 mmol). The mixture was stirred at room temperature until TLC showed complete 
conversion. TBAI (5.6 g, 15.14 mmol) and sodium azide (1 g, 15.14 mmol) were added 
and the mixture was refluxed for 36 h. The mixture was dried on sodium sulfate and 
the solvent was evaporated under reduced pressure. The product was isolated by 
chromatography column (petroleum ether /ethyl acetate, 1/1) to give 2.12 g (10.93 
mmol) of a yellow viscous solid (79%). 
1H NMR (300 MHz, CDCl3) δ  3.74 – 3.57 (m, 10H), 3.33 (t, J = 6 Hz, 2H). 
13C NMR (75 MHz, CDCl3) δ 72.2, 70.2, 69.9, 69.6, 61.2, 50.2. 
ESI-MS (+ve): 216.0513 [M+Na+] (C6H12ClN3O2Na+ requires 216.0510). 










Synthesis 1-azido-2-(2-(2-iodoethoxy)ethoxy)ethane (34) 
 
1-azido-2-(2-(2-chloroethoxy)ethoxy)ethane (2.12 g, 10.85 mmol) was dissolved in 
acetone (10 mL) in a dry round bottom flask equipped with a reflux condenser. Sodium 
iodide (1.43 g, 22 mmol) was added in the mixture refluxed overnight. The mixture was 
cooled at room temperature and filtered through cotton wool. The solvent was 
evaporated under reduced pressure. The resulting solid was taken in deionised water 
and extracted with diethyl ether. The organic phase was dried on magnesium sulfate 
and the solvent was evaporated under reduced pressure to give a yellow viscous liquid 
(3.05 g, 10.70 mmol) (98%). 
1H NMR (300 MHz, CDCl3) δ 3.77 (t, J = 6.8 Hz, 2H), 3.71 – 3.68 (m, 6H), 3.4 (t, J = 
5.0 Hz, 2H), 3.27 (t, J = 6.8 Hz, 2H). 
13C NMR (75 MHz, CDCl3) δ 72.17, 70.84, 70.43, 70.30, 50.87, 3.01. 
ESI-MS (+ve): 307.9868 [M+Na+] (C6H12IN3O2Na+ requires 307.9866). 









Synthesis of 3,8-bis((tert-butoxycarbonyl)amino)-5-(3-iodopropyl)-6-phenyl 
phenanthridin -5-ium (36) 
 
(25) (0.54 g, 1.10 mmol) and 1,3-diiodopropane (5.1 mL, 44 mmol) were dissolved dry 
THF (20 mL) under argon. The solution was refluxed at 65 °C for 2 months until MS 
analysis showed complete conversion. The solvent was evaporated under reduced 
pressure and the mixture was partitioned between ethyl acetate and water. The organic 
phase was dried on magnesium sulfate and the solvent was evaporated to give 0.44 g 
(0.67 mmol) of a yellow solid with (61%). 
1H NMR (300 MHz, CDCl3) δ 9.42 (s, 1H), 9.34 (s, 1H), 8.80 (d, J = 9.3 Hz, 1H), 8.61 
(dd, J = 9.3, 4.3 Hz, 2H), 8.39 (dd, J = 9.1, 2.1 Hz, 1H), 7.82 – 7.77 (m, 3H), 7.51 – 
7.45 (m, 2H), 7.43 (d, J = 2.2 Hz, 1H), 6.99 (s, 1H), 5.16 – 5.02 (m, 2H), 3.51 (t, J = 
6.0 Hz, 2H), 2.42 (bs, 2H), 1.57 (s, 9H), 1.47 (s, 9H).  








Synthesis of 5-(3-azidopropyl)-3,8-bis((tert-butoxycarbonyl)amino)-6-phenyl 
phenanthridin-5-ium (26c) 
 
(36) (228 mg, 0.35 mmol) and sodium azide (70 mg, 1.08 mmol) were dissolved in a 
3:1 mixture of water and acetone (20 mL) under argon atmosphere in a round bottom 
flask equipped with a reflux condenser. The mixture was refluxed overnight, then it was 
cooled at room temperature and acetone was evaporated under reduced pressure. 
The desired product was extracted from the aqueous solution with ethyl acetate. 
Organic phase was dried on magnesium sulfate and the solvent was evaporated under 
reduced pressure to give 174 mg (0.31 mmol) of a yellow solid (89%).  
1H NMR (600 MHz, CDCl3) δ 9.54 (s, 1H), 9.39 (s, 1H), 8.83 (d, J = 9.2 Hz, 1H), 8.61 
(dd, J = 15.9, 9.2 Hz, 2H), 8.37 (d, J = 8.7 Hz, 1H), 7.80 (dd, J = 14.1, 6.7 Hz, 3H), 
7.51 – 7.41 (m, 4H), 5.02 (s, 2H), 3.67 (t, J = 5.8 Hz, 2H), 2.25 (d, J = 23.8 Hz, 2H), 
1.58 (s, 9H), 1.47 (s, 9H).  







Synthesis of 3,11-dihydroxy-3'-oxo-3'H-spiro[dibenzo[c,h]xanthene-7,1'-benzo furan]-
5'(or 6’)-carboxylic acid (39a and 39b)  
 
Benzene-1,2,4-tricarboxylic acid (0.66 g, 3.14 mmol) was dissolved in 7 mL of pure 
methanesulfonic acid in a round bottom flask equipped with a reflux condenser. 
Naphthalene-1,6-diol (1 g, 6.25 mmol) was added. The mixture was heated at 100 °C 
and stirred overnight then it was cooled to room temperature and poured onto 8 
volumes of ice-cold water. The red precipitate was collected and dried under reduced 
pressure. Flash chromatography (10% MeOH in DCM) afforded the product as a red 
solid (1.37 g, 2.37 mmol, 75.47%). The solid (300 mg, 0.63 mmol) was treated with 
copper (II) chloride (0.11 g, 0.82 mmol) in deionised water (10 mL). The solution was 
stirred and sodium persulfate (0.15 g, 0.64 mmol) was slowly added over 30 min. The 
mixture was heated at 90 °C overnight then cooled down and HCl was added to obtain 
a precipitate that was filtrated and dried under reduced pressure. A red solid was 
obtained that was dissolved in methanol and the resulting solution was filtered to 
remove impurities. The filtrate was evaporated under reduced pressure to give a red 
solid (207 mg, 0.36 mmol) with a yield of 43%.  
1H NMR (300 MHz, d6-acetone) δ 8.79 (d, J = 1.8 Hz, 2H), 8.76 (d, J = 1.9 Hz, 2H), 
8.43 – 8.35 (m, 3H), 7.42 (d, J = 2.4 Hz, 2H), 6.87 (d, J = 3.3 Hz, 2H), 6.84 (d, J = 3.3 
Hz, 2H). 




Synthesis of tert-butyl (2-(2-hydroxyethoxy)ethyl)carbamate (45)  
 
2-(2-aminoethoxy)ethan-1-ol (1.6 mL, 15.2 mmol) was diluted in saturated aqueous 
sodium hydrogenocarbonate (50 mL) and the mixture was cooled at 0 °C in an ice 
bath. Di-tert-butyldicarbonate (3.63 g, 16.65 mmol) was added to the mixture dissolved 
in the minimum volume of tetrahydrofuran. The solution was stirred for 30 min at 0 °C 
and overnight at room temperature. The toluene was evaporated and the product was 
extracted with ethyl acetate. Organic phase was dried with magnesium sulfate and the 
solvent was evaporated. The desired compound was purified by flash chromatography 
(2:1 ethyl acetate/petroleum ether). 2.044 g (9.97 mmol) of yellow oil were obtained 
(66%).  
1H NMR (600 MHz, CDCl3) δ 5.58 (s, 1H), 3.94 (s, 1H), 3.35 (s, 2H), 3.24 – 3.15 (m, 
4H), 2.94 (d, J = 3.9 Hz, 2H), 1.08 (s, 9H). 
13C NMR (150 MHz, CDCl3) δ 155.83, 79.24, 71.75, 69.56, 60.62, 39.75, 27.79. 
ESI-MS (+ve): 206.1006 [M+H+] (C9H20NO4+ requires 206.1386). 









Synthesis of tert-butyl (2-(2-azidoethoxy)ethyl)carbamate (46)  
 
(2-(2-hydroxyethoxy)ethyl)carbamate (2 mL, 9.9 mmol) was dissolved in DCM (10 mL) 
in a dry round bottom flask, at 0°C under argon. MsCl (2.12 mL, 15.14 mmol) was 
added dropwise followed by TEA (1.28 mL, 16.51 mmol). The mixture was stirred for 
2 h, it was diluted with DCM (10 mL) and deionised water (10 mL). The organic phase 
was dried with magnesium sulfate and the solvent was evaporated under reduced 
pressure. The crude was taken in DMF (10 mL), sodium azide (1.95 g ,30 mmol) was 
added and the mixture was stirred overnight at 120 °C. The solvent was evaporated 
under reduced pressure and the residue was partitioned between water and DCM. The 
organic phase was dried with magnesium sulfate and the solvent was evaporated 
under reduced pressure to give a 2.2 g of yellow liquid (9.57 mmol) with a yield of 97%. 
1H NMR (300 MHz, CDCl3) δ 4.96 (s, 1H), 3.70 – 3.59 (m, 2H), 3.55 (t, J = 5.2 Hz, 
2H), 3.42 – 3.36 (m, 2H), 3.33 (q, J = 5.5 Hz, 2H), 1.45 (s, 9H). 
13C NMR (75 MHz, CDCl3) δ 155.87, 78.89, 72.39, 69.75, 41.24, 40.11, 28.16 
ESI-MS (+ve): 253.2239 [M+Na+] (C9H18N4O3Na+ requires 253.149). 






Synthesis of 2,5-dioxopyrrolidin-1-yl 3,11-dihydroxy-3'-oxo-3'H-spiro[dibenzo [c,h] 
xanthene-7,1'-benzofuran]-5'(or 6’)-carboxylate (41) 
 
(39) (598 mg, 1.24 mmol) was dissolved in THF (10 mL) in a dry round bottom flask 
under nitrogen and the solution was cooled at 0°C. NHS (0.2 g, 1.73 mmol) and DIC 
(0.25 g, 1.98 mmol) were added and the mixture was allowed reach room temperature. 
After stirring overnight, the solution was treated with n-heptane to induce the 
precipitation of the desired compound. The solid was collected by filtration and dried 
under reduced pressure to get a red solid (576 mg, 1.21 mmol, 98%). 
1H NMR (300 MHz, CDCl3) δ 8.26 (d, J = 9.2 Hz, 2H), 8.11 (dd, J = 9.1, 3.5 Hz, 2H), 
7.74 (s, 1H), 7.72 – 7.63 (m, 2H), 7.57 (s, 1H), 7.53 (s, 1H), 7.26 (d, J = 8.2 Hz, 2H), 
7.12 (s, 2H), 2.94 – 2.86 (m, 4H). 








Synthesis of N-(2-(2-azidoethoxy)ethyl)-3,11-dihydroxy-3'-oxo-3'H-spiro[dibenzo 
[c,h]xanthene-7,1'-benzofuran]-5'(or 6’)-carboxamide (42) 
 
Compound (46) (4.2 g, 7.17 mmol) was dissolved in a 2:5 mixture of TFA/DCM (10 
mL) in a round bottom flask and the solution was stirred at room temperature until TLC 
showed complete conversion. The solvent was evaporated under reduced pressure 
and the residue was washed with diethyl ether. The dried crude was dissolved in a 5:1 
mixture of DCM and DMF (10 mL) and treated with compound (41) (1.37 g, 2.39 mmol) 
at 0°C under argon. TEA (967 mg, 9.56 mmol) was slowly added, the mixture was 
allowed to reach room temperature and it was stirred overnight. The solvent was 
removed under reduced pressure and the resulting solid was dissolved in MeOH and 
filtered through paper. The filtrate was evaporated to dryness to give a red solid (869 
mg, 1.48 mmol, 62%). 
1H NMR (300 MHz, MeOD) δ 8.53 (s, 1H), 8.16 – 8.19 (m, 2H), 7.76 (s, 1H), 7.70 – 
7.61 (m, 2H), 7.41 – 7.44 (m, 4H), 7.12 (d, J = 11.8 Hz, 2H), 6.72 (dd, J = 8.7, 3.8 Hz, 
2H), 3.73 – 3.68 (m, 2H), 3.56 – 3.51 (m, 2H), 3.20 (d, J = 5.1 Hz, 2H), 1.29 (bs, 2H). 









Compound (42) (62 mg, 0.11 mmol) was dissolved in dry THF (20 mL) in a round 
bottom flask under argon atmosphere and the solution was cooled at 0 °C. TEA (50 
µL, 3.62 mmol) was added to the solution dropwise followed by a solution of Ph2P(O)Cl 
(54.3 mg, 0.23 mmol) in dry THF (5 mL). The mixture was stirred overnight and allowed 
to reach room temperature. The solution was filtered and evaporated under reduced 
pressure. The crude was dissolved in benzene (10 mL) and washed twice with of 
diluted ammonia (10 mL) and twice with deionised water (10 mL). The organic phase 
was dried on magnesium sulfate and the solvent was evaporated under reduced 
pressure to give a red solid (25 mg, 0.03 mmol) with a yield of 23%. 
1H NMR (300 MHz, CDCl3) δ 8.49 (dd, J = 9.0, 2.8 Hz, 1H), 7.85 (dd, J = 12.2, 7.4 Hz, 
8H), 7.76 – 7.67 (m, 3H), 7.41 – 7.37 (m, 8H), 7.16 (s, 2H), 6.88 (d, J = 0.5 Hz, 10H), 
6.65 (dd, J = 8.7, 4.3 Hz, 2H), 3.80 – 3.74 (m, 2H), 3.67 (d, J = 11.1 Hz, 2H), 3.58 – 
3.54 (m, 2H), 1.96 – 1.92 (m, 2H). 
13C NMR (75 MHz, CDCl3) δ 132.72, 131.91, 131.77, 131.62, 128.83, 128.65, 128.50, 


























Synthesis of 2-(2,4-dihydroxybenzoyl) benzoic acid (49)  
 
Under an argon atmosphere, resorcinol (2.40 g, 16.89 mmol) and phthalic anhydride 
(2.34 g, 15.80 mmol) were dissolved in dry nitrobenzene (50 mL). The mixture was 
cooled to 0°C and aluminium (III) chloride (4.90 g, 36.74 mmol) was added. The 
resulting dark olive slurry was allowed to warm to room temperature and stirred for an 
additional 16 h under argon. The reaction was poured into a vigorously stirring mixture 
of petroleum ether (360 mL) and 1 M HCl (150 mL). The precipitate was filtered and 
recrystallized twice from MeOH and water (1:1) to afford benzophenone as a pale 
green powder (2.4 g, 9.3 mmol) with 60% of yield. 
1H NMR (300 MHz, DMSO-d6) δ 13.19 (s, 1H), 12.24 (s, 1H), 10.71 (s, 1H), 8.00 (dd, 
J= 7.7 Hz, 0.9 Hz, 1H), 7.74-7.67 (m, 1H), 7.65-7.61 (m, 1H),7.42 (dd, J= 7.5, 1.0 Hz, 
1H), 6.95-6.90 (m, 1H), 6.33 (d, J= 2.3 Hz, 1H), 6.29 (dd, J= 8.7, 2.3 Hz, 1H). 
13C NMR (75 MHz, DMSO-d6) δ 200.51, 166.76, 165.01, 164.42, 140.00, 134.75, 
132.32, 129.99, 129.74, 129.48, 127.45, 113.29, 108.34, 102.55. 
ESI-MS (-ve): 257.110 [M+H+] (C14H9O5- requires 257.0455). 







Synthesis of Fmoc-piperazine rhodol (51)  
 
(49) (618 mg, 2.39 mmol) and 1-(3-hydroxyphenyl)-piperazine (427 mg, 2.39 mmol) 
were added to a round bottomed flask and dissolved in 10 mL of TFA under a gentle 
stream of argon. The reaction was stirred for 3 hours at 95 °C. After cooling, the 
reaction mixture was poured into 300 mL of diethyl ether under vigorous stirring. The 
resulting precipitate was collected, immediately dissolved in methanol, and then 
evaporated to dryness under reduced pressure to yield a red solid. The crude product 
was used without further purification. The crude fluorophore (1.2 g), Fmoc-Cl (930 mg, 
3.63 mmol), and NaHCO3 (755 mg, 8.99 mmol) were added to a dry round bottomed 
flask under argon atmosphere. Acetonitrile (20 mL) was added and the reaction was 
stirred at room temperature overnight. The product was then poured into ethyl acetate 
(150 mL), washed with water (x5), with brine (x5) and dried over Na2SO4 and 
evaporated. Purification by flash chromatography (1:1 petroleum ether/ethyl acetate) 
afforded a red solid (628 mg, 1mmol) with 42% of yield. 
1H NMR (300 MHz, CDCl3): δ 7.99 (d, J = 7.6 Hz, 1H), 7.74 (d, J = 7.6 Hz, 2H), 7.66-
7.57 (m, 2H), 7.55 (d, J = 7.6 Hz, 2H), 7.37 (t, J = 7.2 Hz, 2H), 7.29 (t, J = 7.2 Hz, 2H), 
7.14 (d, J = 7.6 Hz, 1H), 6.71 (d, J = 2.0 Hz, 1H), 6.65 (d, J = 2.0 Hz, 1H), 6.63-6.29 
(m, 4H), 4.47 (d, J = 6.4 Hz, 2H), 4.22 (t, J = 6.4 Hz, 1H), 3.55 (bs, 4H), 3.14 (bs, 4H). 
13C NMR (75 MHz, CDCl3): δ 170.03, 159.59, 155.23, 152.82, 152.65, 152.58, 152.41, 




124.82, 124.18, 129.97, 112.59, 112.18, 110.35, 109.87, 102.82, 102.33, 67.37, 47.99, 
47.25, 43.20. 
ESI-MS (+ve): 623.2182 [M+H+] (C39H31N2O6+ requires 623.2176). 



















Synthesis of Fmoc-piperazine rhodol triflate (52)  
 
(50) (622 mg, 1 mmol), N-phenyl bis(trifluoromethanesulfonamide) (628 mg, 1.01 
mmol), and sodium carbonate (535 mg, 5.05 mmol) were added to a dry round 
bottomed flask. Dry DMF (15 mL) was added via syringe. The reaction mixture 
changed colour from red to orange within 15 minutes and it was allowed to stir under 
argon atmosphere at room temperature overnight. The reaction mixture was poured 
into 100 mL of ethyl acetate, washed with water (x5), dried over magnesium sulfate, 
filtered and evaporated. Purification by column chromatography (petroleum ether/ethyl 
acetate, 1:1) afforded a white solid (297.4 mg, 0.4 mmol) in 39% of yield. 
1H NMR (300 MHz, CDCl3): δ 8.04 (d, J = 7.2 Hz, 1H), 7.76 (d, J = 7.6 Hz, 2H), 7.69 
(dt, J = 1.2, 7.6 Hz, 1H), 7.64 (dt, J = 7.6, 1.2 Hz, 1H), 7.57 (d, J = 7.2 Hz, 2H), 7.38 (t, 
J = 7.2 Hz, 2H), 7.30 (dt, J = 1.2, 7.2 Hz, 2H), 7.23 (d, J = 2.4 Hz, 1H), 7.16 (d, J = 7.2 
Hz, 1H), 6.94 (dd, J = 2.4, 8.8 Hz, 1H), 6.88 (d, J = 8.8 Hz, 1H), 6.70 (d, J = 2.0 Hz, 
1H), 6.66 (d, J = 8.8 Hz, 1H), 6.61 (dd, J = 2.0, 8.8 Hz, 1H), 4.48 (d, J = 2.4 Hz, 2H), 
4.23 (t, J = 2.4 Hz, 1H), 3.56 (bs, 4H), 3.16 (bs, 4H). 
13C NMR (75 MHz, CDCl3): δ 169.18, 155.09, 152.77, 152.49, 152.18, 151.85, 149.93, 
143.83, 141.31, 135.37, 130.14, 130.06, 128.73, 127.73, 127.07, 126.36, 125.23, 
124.86, 123.87, 119.98, 119.86, 116.52, 112.78, 110.42, 108.77, 102.23, 81.96, 67.29, 




ESI-MS (+ve): 777.1501 [M+Na+] (C40H29F3N2O8SNa+ requires 777.1494). 





















Synthesis of Fmoc-piperazine rhodol boronate (53)  
 
(52) (180 mg, 0.23mmol), bis(pinacolato)diboron (58.19 mg, 0.23 mmol), sodium 
acetate (53.77 mg, 0.65 mmol), and toluene (20 mL) were placed in a dry microwave 
tube and the mixture was purged with argon for 10 minutes. Pd(dppf)Cl2∙ CH2Cl2 (58.65 
mg, 0.07 mmol) was then added, the tube was sealed and microwave-heated for 4 
hours at 110 °C. After cooling the reaction to room temperature, the contents of the 
tube were washed into a round bottom flask with dichloromethane and evaporated to 
dryness. Purification by column chromatography (petroleum ether/ethyl acetate, 2:3) 
afforded a white solid (100 mg, 0.13 mmol, 60%). 
1H NMR (300 MHz, CDCl3): δ 8.02 (d, J = 6.4 Hz, 1H), 7.77 (t, J = 7.6 Hz, 3H), 7.68-
7.56 (m, 4H), 7.45-7.37 (m, 3H), 7.33 (t, J = 8.0 Hz, 2H), 7.22 (d, J = 6.8 Hz, 1H), 6.81 
(d, J = 8.0 Hz, 1H), 6.69 (d, J = 7.6 Hz, 2H), 6.59 (dd, J = 2.4, 8.8 Hz, 1H), 4.50 (d, J = 
6.8 Hz, 2H), 4.26 (t, J = 6.4 Hz, 2H), 3.60 (bs, 4H), 3.16 (bs, 4H), 1.35 (s, 12H). 
13C NMR (75 MHz, CDCl3): δ 169.65, 155.09, 153.44, 152.69, 152.31, 150.84, 143.88, 
141.34, 153.09, 129.70, 129.27, 128.73, 128.04, 127.75, 127.25, 127.09, 126.37, 
125.07, 124.90, 123.82, 123.44, 121.60, 120.01, 112.27, 109.47, 102.60, 84.20, 82.85, 
67.29, 48.13, 47.34, 24.86.  


























spiro[isobenzofuran-1,9'-xanthen]-6'-yl)piperazin-1-yl)butanoic acid (54) 
 
(53) (90 mg, 0.12 mmol) was dissolved in 12 mL of 15% piperidine in acetonitrile and 
stirred at room temperature for 40 minutes. The reaction was then dried under reduced 
pressure and left 10 minutes under argon stream. Then chloroform (2 mL) and DIPEA 
(0.194 g, 1.5 mmol) were added. The mixture was cooled to 0°C and succinic 
anhydride (0.015 g, 0.15 mmol) was added slowly. The reaction mixture was warmed 
to room temperature and stirred overnight. The solvent was removed under reduced 
pressure and 70 mg of crude product were obtained. 












yl)piperazin-1-yl)-4-oxobutanoic acid (56) 
 
(49) (309 mg, 1.19 mmol) and 1-(3-hydroxyphenyl)-piperazine (213.5 mg, 1.2 mmol) 
were added to a round bottomed flask and dissolved in 10 mL of TFA under a stream 
of argon. The reaction was stirred for 3 hours at 95 °C, then it was cooled and poured 
in 300 mL of diethyl ether under vigorous stirring. The resulting precipitate was 
collected, dissolved in methanol and evaporated to dryness under reduced pressure 
to yield a red solid. The solid was dissolved in DMF (20 mL) at 0 °C under nitrogen and 
treated with succinic anhydride (263 mg, 3.63 mmol) and DIPEA (1 mL, 5 µmol). After 
stirring overnight, DMF was evaporated under reduced pressure. The solid was 
dissolved in ethyl acetate and washed with water and solvent evaporated to give a red 
solid (320 mg, 0.64 mmol, 54%). 
1H NMR (300 MHz, CDCl3) δ 7.99 (s, 2H), 7.33 – 7.25 (m, 4H), 7.06 (dd, J = 10.5, 4.2 
Hz, 2H), 7.00 – 6.93 (m, 4H), 1.50 – 1.46 (m, 4H), 1.40 (d, J = 6.6 Hz, 4H), 0.84 (dd, J 
= 9.8, 5.3 Hz, 4H). 










(56) (172 mg, 0.34 mmol) was mixed in a dry round bottom flask with potassium 
carbonate (84 mg, 0.61 mmol) and 2-(3-(bromomethyl)phenyl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (102 mg, 0.35 mmol) in DMF (10 mL) under nitrogen. The mixture 
was stirred overnight and the solvent was evaporated under reduced pressure. The 
solid was partitioned between DCM and deionised water. The organic phase was dried 
on magnesium sulfate and the solvent evaporated under reduced pressure to afford a 
red solid (101 mg, 0.13 mmol, 38%). 
1H NMR (300 MHz, CDCl3) δ 7.53 (d, J = 4.8 Hz, 1H), 6.70 (d, J = 2.3 Hz, 3H), 6.59 (s, 
2H), 6.26 (dd, J = 7.7, 0.9 Hz, 3H), 6.19 (d, J = 7.3 Hz, 3H), 6.10 (d, J = 9.6 Hz, 3H), 
4.38 (dd, J = 15.0, 6.3 Hz, 4H), 4.24 (q, J = 12.1 Hz, 4H), 2.96 (d, J = 2.0 Hz, 6H), 0.63 
(s, 12H). 
13C NMR (75 MHz, CDCl3) δ 185.47, 173.52, 170.03, 165.33, 158.86, 154.43, 153.75, 
150.24, 137.36, 135.02, 134.43, 132.63, 131.36, 130.51, 130.36, 130.18, 129.73, 
129.58, 129.10, 128.95, 127.23, 126.50, 118.88, 116.51, 112.96, 111.52, 105.58, 


























Synthesis of phenyl(2,4,5-trimethylphenyl)ketone (61)  
 
Benzoyl chloride (19 mL, 164 mmol) was dissolved in DCM (30 mL) at 0 °C in a round 
bottom flask under nitrogen. AlCl3 (26.17 g, 196.8 mmol) was added. 1,2,4-
trimethylbenzene (19.43 mL, 141 mmol) was added dropwise. The mixture was 
allowed to reach room temperature and stirred for 6 h, then it was poured on ice bath 
containing 25 mL of concentrated HCl. The organic phase was separated, dried with 
magnesium sulfate and the solvent was evaporated under reduced pressure to give a 
brown solid (33.82 g, 138 mmol, 98%). 
1H NMR (300 MHz, CDCl3) δ 7.83 – 7.70 (m, 2H), 7.53 – 7.29 (m, 4H), 6.99 (s, 1H), 
2.26 (s, 3H), 2.21 (s, 3H), 2.15 (s, 3H). 
13C NMR (75 MHz, CDCl3) δ 198.2, 138.9, 138.0, 135.8, 134.2, 133.0, 132.5, 132.2, 
129.9, 129.7, 129.1, 128.5, 128.1, 19.35, 19.29, 18.8. 
ESI-MS (+ve): 247.0574 [M+Na+] (C16H16ONa+ requires 247.1093). 









Synthesis of 5-benzoylbenzene-1,2,4-tricarboxylic acid (62)  
 
(61) (2.08 g, 9.29 mmol), KMnO4 (16 g, 101.26 mmol) and pyridine (7 mL, 86.84 mmol) 
were dissolved in deionised water (20 mL) in a round bottom flask. The mixture was 
stirred at 50 °C for 5 days and filtered while hot. The solid was taken in deionised water 
(50 mL), boiled for 6 h and filtered again. The two filtrates were combined, the water 
was evaporated to half its volume and concentrated HCl was added to reach pH = 1 to 
induce the precipitation of the product. The solid was collected by filtration and dried 
under reduced pressure to give a brown solid (2.74 g, 8.71 mmol, 94%). 
1H NMR (300 MHz, (CD3)2CO) δ 8.49 (s, 1H), 7.80 – 7.76 (6, 3H), 7.64 – 7.51 (m, 3H). 
13C NMR (75 MHz, (CD3)2CO) δ 181.4, 167.6, 137.5, 134.9, 134.2, 132.9, 127.0, 126.9. 
ESI-MS (-ve): 313.1055 [M+H+] (C16H9O7- requires 313.0354). 





Alternative synthesis of 5-benzoylbenzene-1,2,4-tricarboxylic acid (62) 
 
(61) (1 g, 4.46 mmol), KMnO4 (5.4 g, 34.18 mmol) and NaHCO3 (0.2 g, 2.38 mmol) 
were dissolved in deionised water (25 mL) in a round bottom flask equipped with a 
reflux condenser and refluxed overnight. The mixture was filtered, the filtrate was 
treated with 12 M HCl to pH = 1 and the desired product was extracted with DCM. The 
organic phase was dried with sodium sulfate and the solvent was evaporated under 
reduced pressure to give a brown solid (203 mg, 0.65 mmol, 15%). 
1H NMR (300 MHz, (CD3)2CO) δ 8.49 (s, 1H), 7.80 – 7.76 (6, 3H), 7.64 – 7.51 (m, 3H). 
13C NMR (75 MHz, (CD3)2CO) δ 181.4, 167.6, 137.5, 134.9, 134.2, 132.9, 127.0, 126.9. 
ESI-MS (-ve): 313.1055 [M+H+] (C16H9O7- requires 313.0354). 











Synthesis of 9,10-dioxo-9,10-dihydroanthracene-2,3-dicarboxylic acid (63)  
 
(62) (550 mg, 1.75 mmol) was refluxed in concentrated sulfuric acid (20 mL) for 3 h in 
a round bottom flask equipped with a reflux condenser. The solution was cooled to 
room temperature, poured on ice stirred for 2 days at room temperature. The solid was 
filtered and dried to give a brown solid (277 mg). The product was purified by a flash 
chromatography (petroleum ether/ethyl acetate 1:1) to give a brown solid (206 mg, 
0.70 mmol, 40%). 
1H NMR (300 MHz, (CD3)2CO) δ 8.61 (s, 2H), 8.36 – 8.32 (m, 2H), 8.01 – 7.94 (m, 2H). 
13C NMR (75 MHz, (CD3)2CO) δ 181.4, 167.6, 137.5, 134.9, 134.2, 132.9, 127.0, 126.9. 
ESI-MS (-ve): 295.0963 [M+H+] (C16H7O6- requires 295.0248). 










Synthesis of anthra[2,3-c]furan-1,3,5,10-tetraone (64) 
 
(63) (100 mg, 0.34 mmol) was mixed with 10 mL of glacial acetic acid for 1 day in a dry 
round bottom flask under nitrogen. The solid was filtered, rinsed with petroleum ether 
and dried under reduced pressure to give a green solid (58.6 mg, 0.21 mmol, 62%). 
1H NMR (600 MHz, (CD3)2CO), δ: 8.83 (s, 2H), 8.39 (dd, J = 5.8, 3.3 Hz, 2H), 8.06 (dd, 
J = 5.9, 3.2 Hz, 2H). 







Synthesis of 9,10-bis(bromomethyl)anthracene (71)  
 
Dimethylanthracene (282 mg, 1.37 mmol), NBS (487 mg, 2.75 mmol) and AIBN (0.1 
ml, 0.7 mmol) were dissolved in acetonitrile (50 mL) in a round bottom flask under 
nitrogen. The mixture was refluxed for 1.5 h. The solid was collected by filtration, 
dissolved in DCM and washed with saturated aqueous NaHCO3, water and brine. The 
organic phase was dried on sodium sulfate and the solvent was evaporated under 
reduced pressure.  
1H NMR (300 MHz, CDCl3) δ 8.45 – 8.30 (m, 4H), 7.73 – 7.64 (m, 4H), 5.52 (s, 4H). 
13C NMR (75 MHz, CDCl3) δ 126.70, 124.38, 75.89. 
ESI-MS (+ve): 280.1359 [M-Br-] (C16H9Br+ requires 280.9817). 










Synthesis of 3,3'-(anthracene-9,10-diyl)dipropionic acid (72b) 
 
Sodium (750 mg, 32.61 mmol) was dissolved in EtOH (125 mL) in a round bottom flask 
equipped with a reflux condenser under nitrogen. Dry diethyl malonate (10 mL) was 
added while the mixture was kept at 5 °C to avoid precipitation and stirred for an hour. 
A solution of (71) (248 mg, 0.68 mmol) in benzene (175 mL) was added. The mixture 
was refluxed for 4 h then it was allowed to cool at room temperature. The solution was 
neutralized with concentrated HCl. The organic phase was separated and the solvent 
was evaporated under reduced pressure. The solid was treated with 6 M NaOH (10 
mL) in methanol and 5 mL of chloroform and the resulting solution was refluxed for 3 
hours. Concentrated HCl was added to reach pH = 1 and the resulting suspension as 
filtered. The solid was dried for 5 days under reduced pressure at 120 °C to give a 
green solid (46 mg, 0.12 mmol, 18%) 
1H NMR (600 MHz, DMSO) δ 13.16 – 12.43 (s, 2H), 8.38 – 8.30 (m, 4H), 7.57 – 7.31 
(m, 4H), 4.10 (d, J = 7.0 Hz, 4H), 3.51 – 3.41 (m, 4H). 
13C NMR (125 MHz, CDCl3) δ 130.23, 129.57, 126.65, 124.33, 45.86, 26.66. 






Synthesis of (58)- and (72b)-PLGA 
PLGA from Sigma Aldrich (M = 86,500 g/mol) (500 mg) was dissolved in DCM (10 mL) 
and the solution was cooled at 0°C. An excess of NHS (2.7 mg) and DIC (2.9 mg) were 
added and the mixture was stirred overnight at room temperature. An excess of 1,3-
diaminopropane (1.4 mg) was added and the solution was stirred overnight. The 
solution was divided between two centrifuge tubes, diethyl ether (40 mL) was added to 
each tube and the resulting suspension was centrifuged (3000 rpm, 620 G, 5 min). The 
pellet was dissolved in DCM (5 mL), precipitated with diethyl ether and centrifuged 
(3000 rpm, 620 G, 5 min) for three times. The polymer was dried under reduced 
pressure to collect 497 mg. The sensor (7.44 mg of (72) or 16.56 mg (58)) was 
dissolved in THF or DCM (10 mL), respectively, at 0°C. An excess of NHS (5.36 mg) 
and DIC (5.84 mg) were added and the mixture was stirred at room temperature 
overnight. The amino-functionalised PLGA was added, followed by overnight stirring. 
The precipitate was collected by centrifugation (3000 rpm, 620 G, 5 min) The pellet 
was dissolved in DCM (5 mL), precipitated with diethyl ether and centrifuged (3000 
rpm, 620 G, 5 min) for three times. The polymer was dried and gave a yellow pellet for 
(72b) and a pink pellet for (58). For 500 mg of PLGA, 465 mg of (72b) PLGA were 
created and 105 mg of (58) PLGA. 
(58)-PLGA: FTIR (C=O stretch) 1638 cm-1, (N-H stretch) 3306 cm-1. 





Synthesis of (43)-PLGA 
PLGA (500 mg) was dissolved in DCM (10 mL) and cooled at 0 °C. An excess of NHS 
(2.68 mg) and DIC (2.92 mg) were added and the mixture was stirred overnight at room 
temperature. An excess of aza-dibenzocyclooctyne (ADIBO) amine (6.38 mg) was 
added, followed by overnight stirring. The solution was divided between two centrifuge 
tubes, diethyl ether (40 mL) was added to each tube and the resulting suspension was 
centrifuged (3000 rpm, 620 G, 5 min). The pellet was dissolved in DCM (5 mL), 
precipitated with diethyl ether and centrifuged (3000 rpm, 620 G, 5 min) for three times. 
The polymer was dried under reduced pressure to collect 457 mg. (43) (22.84 mg) was 
dissolved in DCM (10 mL) and the cyclooctyne-modified PLGA was added and the 
mixture was stirred overnight. The solid was precipitated with diethyl ether, collected 
by centrifugation and further purified by washing with diethyl ether to give 122 mg of a 
pink solid. 











Synthesis of (15a)-PLGA 
PLGA (50 mg) was dissolved in DCM (10 mL) and cooled at 0 °C. NHS (0.3 mg) and 
DIC (0.3 mg) were added and the mixture was stirred overnight at room temperature. 
An excess of 1,3-propanediamine (0.2 mg) was added and stirring was continued 
overnight. The solution was divided between two centrifuge tubes, diethyl ether (40 
mL) was added to each tube and the resulting suspension was centrifuged (3000 rpm, 
620 G, 5 min). The pellet was dissolved in DCM (5 mL), precipitated with diethyl ether 
and centrifuged (3000 rpm, 620 G, 5 min) for three times. The resulting white pellet 
was dried under reduced pressure to collect 48 mg. (15a) (1 mg) was dissolved in 10 
mL THF at 0 °C and NHS (0.6 mg) and DIC (0.6 mg) were added stirring was continued 
overnight at room temperature. The amino-modified PLGA was added and stirring was 
continued overnight. The solution was divided between two centrifuge tubes, diethyl 
ether (40 mL) was added to each tube and the resulting suspension was centrifuge 
(3000 rpm, 620 G, 5 min). The pellet was dissolved in DCM (5 mL), precipitated with 
diethyl ether and centrifuged (3000 rpm, 620 G, 5 min) for three times. The polymer 










General procedure for preparation of PLGA, (43)-, (72b)-, (58)- and (15a)-PLGA NPs 
via single emulsion solvent evaporation  
10 mg of PLGA was dissolved in 0.4 mL of DCM. 4 mL of 1 % PVA in water was placed 
in an ice bath. The cooled PVA solution was ultra-sonicated, and the PLGA solution 
was added dropwise during the first 30 sec of sonication for a total of 2 min with 65% 
of amplitude. The solution was then mechanically stirred at 500 rpm and 52 G fat room 
temperature. For sensor-PLGA this step was carried out in the dark and under nitrogen. 
After 1 hour the solution was ultra-centrifuged at 35,000 rpm and 84,378 G at -4 °C for 
40 min. The supernatant was discarded and deionised water was added, the solid was 
suspended and another centrifugation carried out. The supernatant was discarded and 
the particles suspended in 10 mL of PBS solution to have approximatively 1 mg/mL 













General procedure for encapsulation of (1a) and (73) in PLGA NPs  
10 mg of PLGA and 1 mg of (1a) or (73) were dissolved in 0.4 mL of DCM. 4 mL of 1% 
PVA in water was cooled and then ultra-sonicated. The DCM solution was added 
dropwise during the first 30 sec of sonication for a total of 2 min with 65% of amplitude. 
The solution was then mechanically stirred at 500 rpm and 52 G at room temperature. 
For polymer with sensors this step carried out in the dark and under nitrogen. After 1 
hour the solution was centrifuged at 35,000 rpm and 84,378 G at -4 °C for 40 min. The 
supernatant was discarded and the solid was resuspended in deionised water and 
second centrifugation carried out. The supernatant was discarded and the polymer was 
suspended in 10 mL of PBS solution to have approximatively 1 mg/mL suspension of 














General procedure for PLGA NP formulation using double emulsion solvent 
evaporation 
A 1% PVA solution in water (100 µL) was added over 30 seconds to a solution of 10 
mg of PLGA in 0.4 mL of DCM maintained in an ice bath and sonication (65% of 
amplitude) for 2 minutes. The resultant water-in-oil suspension was added to 4 mL of 
1% aqueous PVA in an ice bath under the same sonication conditions described 
above. 
The emulsion was then mechanically stirred at 500 rpm at room temperature. After 1 
hour the solution was centrifuged at 35,000 rpm and 84,378 G at -4 °C for 40 min. The 
supernatant was discarded and deionised water was added, the solid was suspended 
and another centrifugation carried out. The supernatant was discarded and the 
polymer was suspended in 10 mL of PBS solution to have approximatively 1 mg/mL 












Response to ROS: 
Superoxide anion 
1 mg of (43) was dissolved in a mixture of 1 mL of DMSO and 9 mL of PBS (pH = 7.4). 
A 10 µM solution of Xa was prepared in PBS. In a cuvette, 3 mL of the sensor solution 
was mixed with 100 µL of Xa solution and 2 µL of catalase (10-40 kU/mg) (to remove 
hydrogen peroxide as it forms in order to avoid interferences). Different volumes (0-20 
µL) of XO were added and the emission spectra (exc/em = 490/540 nm) were recorded 
in function of the XO concentration. 
Hydrogen peroxide 
1 mg (58) was dissolved in a mix of 1 mL of DMSO and 9 mL of PBS (pH = 7.4). A 
solution of 2.2 µM of hydrogen peroxide was prepared in PBS. 3 mL of the sensor 
solution were placed in a cuvette and different concentrations (0-2.94 µmol) of 
hydrogen peroxide solution were added. Emission spectra (exc/em = 515/540 nm) 
were recorded for different hydrogen peroxide concentration. 
Singlet oxygen 
1 mg of (72) was dissolved 10 mL of EtOH and 5 mg of porphyrin was diluted in 10 mL 
ethanol. In a cuvette, 3 mL of sensor solution were mixed with 3 µL of the solution with 
porphyrin. The mixture was then exposed to blue light at different time (0-150 sec) and 







Fluorescence characterization of NPs: 
Superoxide anion 
1 mL of sensor solution at 1 mg/mL of sensor on PLGA was dissolved in a mix of 1 mL 
of dimethylsulfoxide (DMSO) and 9 mL of phosphate buffer solution (PBS) at a pH of 
7.4. A solution of 10 µM of Xa was prepared in PBS. In a cuvette for fluorimeter, 3 mL 
of the sensor solution was mixed with 100 µL of Xa solution and 2 µL of catalase that 
transforms the resulted hydrogen peroxide into water to avoid interferences. Then 
different volumes of XO were added to give fluorescent spectra depending on XO 
concentration. 
Hydrogen peroxide 
1 mL of sensor solution at 1 mg/mL of sensor on PLGA was dissolved in a mix of 1 mL 
of DMSO and 9 mL of PBS at a pH of 7.4. A solution of 2.2 µM of hydrogen peroxide 
was prepared in PBS. In a cuvette for fluorometer, 3 mL of the sensor solution was 
added. Then, different volumes of hydrogen peroxide solution were added to give 
fluorescent spectra depending on hydrogen peroxide concentration. 
Singlet oxygen 
1 mL of sensor solution at 1 mg/mL of sensor on PLGA of sensor was dissolved 10 mL 
of EtOH and 5 mg of this porphyrin was diluted in 10 mL ethanol. In a cuvette for 
fluorimeter, 3 mL of sensor solution was added with 3 µL of the solution with porphyrin. 






Sample preparation for confocal microscopy 
Nanosensors (1 mg/mL in PBS, pH = 7.4) or stand-alone sensors (2 mg/mL in DMSO 
diluted in 9.5 mL of PBS, pH = 7.4) were used. 300 µL of cells suspension was mixed 
with 100 µL of sensors solution in an Eppendorf vial. The mixture was incubated at 
37°C with 5% of CO2 for 30 min. 50 µL of PMA at 2.5 µM was added and the solution 
was incubated with the same condition of temperature and atmosphere for 10 min. The 
solution was centrifuged at 5,000 rpm and 1,722 G for 5 min. The supernatant was 
discarded and 5 ml PBS was added to make a new suspension and wash cells, which 
was centrifuged and washed one more time. Cells were suspended in 1 mL of PBS, a 
drop of the suspension was placed on a microscope slide and a coverslip with a 1.5 
focal was slowly deposited on the sample, which was examined at the microscope. 
Parameters: laser intensity at 1.2 %, filter between 493 and 630 nm, pinhole at 47 µm, 












Sample preparation for flow cytometry tests 
Cytotoxicity 
To 100 µL of cells suspension, different volumes of sensor solution (1 mg/mL) were 
added. Cells were incubated for 30 min at 37°C with 5% of CO2 and the suspension 
was analysed on the flow cytometer. 
PMA exposure time 
100 µL of cells in media were incubated with 50 µL of sensors solution (1 mg/mL) at 
37 °C in 5% of CO2. After 30 min, 20 µL of PMA at 2.5 µM were added. The mixture 
was incubated in the same condition described above for different times (0-30 min). 
Measurement of the fluorescence though the filter between 533 nm and 630 nm were 
taken to follow the evolution of the fluorescence. 
PMA concentration 
100 µL of cells in media were incubated with 50 µL of sensors solution at 1 mg/mL at 
37 °C in 5% of CO2 for 30 min. Different volumes (0-20 µL) of PMA at 2.5 µM were 
added. The mixture was incubated in the same condition described above for 30 min. 
Measurement of the fluorescence though the filter between 533 nm and 630 nm were 
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